Quarterly Report • Nov 14, 2019
Quarterly Report
Open in ViewerOpens in native device viewer

KBC Group I Quarterly Report – 3Q2019 I p.1
Summary 3 Financial highlights 4 Overview of results and balance sheet 5 Analysis of the quarter 6 Analysis of the year-to-date period 8 Risk statement, economic views and guidance 9
Consolidated income statement 12 Consolidated statement of comprehensive income 14 Consolidated balance sheet 15 Consolidated statement of changes in equity 16 Consolidated cash flow statement 18 Notes on statement of compliance and changes in accounting policies 19 Notes on segment reporting 20 Other notes 21
Credit risk 34 Solvency 40 Income statement, volumes and ratios per business unit 44 Details of ratios and terms 52
'I, Rik Scheerlinck, Chief Financial Officer of the KBC Group, certify on behalf of the Executive Committee of KBC Group NV that, to the best of my knowledge, the abbreviated financial statements included in the quarterly report are based on the relevant accounting standards and fairly present in all material respects the financial condition and results of KBC Group NV including its consolidated subsidiaries, and that the quarterly report provides a fair view of the main events, the main transactions with related parties in the period under review and their impact on the abbreviated financial statements, and an overview of the main risks and uncertainties for the remainder of the current year.'
The expectations, forecasts and statements regarding future developments that are contained in this report are, of course, based on assumptions and are contingent on a number of factors that will come into play in the future. Consequently, the actual situation may turn out to be (substantially) different.
Investor Relations contact details [email protected] KBC Group NV, Investor Relations Office, Havenlaan 2, 1080 Brussels, Belgium
This report contains information that is subject to transparency regulations for listed companies. Date of release: 14 November 2019
Check this document's authenticity at www.kbc.com/en/authenticity.
Report for 3Q2019

| KBC Group - overview (consolidated, IFRS) | 3Q2019 | 2Q2019 | 3Q2018 | 9M2019 | 9M2018 |
|---|---|---|---|---|---|
| Net result (in millions of EUR) | 612 | 745 | 701 | 1 787 | 1 948 |
| Basic earnings per share (in EUR) | 1.44 | 1.76 | 1.63 | 4.19 | 4,54 |
| Breakdown of the net result by business unit (in millions of EUR) | |||||
| Belgium | 368 | 388 | 409 | 932 | 1 089 |
| Czech Republic | 159 | 248 | 168 | 584 | 484 |
| International Markets | 85 | 104 | 141 | 260 | 440 |
| Group Centre | 0 | 4 | -17 | 10 | -64 |
| Parent shareholders' equity per share (in EUR, end of period) | 43.5 | 42.8 | 40.6 | 43.5 | 40.6 |
We generated a net profit of 612 million euros in the third quarter of 2019. Compared to the previous quarter, the quarter under review was characterised by higher net interest income and net fee and commission income, a virtually stable level of technical income from our insurance activities and a decrease in both costs and loan loss impairments. On the other hand, trading and fair value income was very weak due mainly to poor dealing room income, dividend income was seasonally lower and there was a significant drop in net other income. The latter development came about because the previous quarter had benefited from an 82-million-euro gain related to the acquisition of the remaining 45% stake in the Czech building savings bank, ČMSS.
Adding the third-quarter result to the 1 175 million euros recorded in the first half of the year brings our result for the first nine months of 2019 to a solid 1 787 million euros.
On a comparable scope basis, our loans to customers increased by 4% year-on-year and deposits (including debt certificates) were up by 4%, as well. Sales of our non-life and life insurance products also went up year-on-year, by 9% and 5%, respectively.
Our solvency position, which does not include the profit for the first nine months of the year, remained strong too, with a common equity ratio of 15.4%. If we had included the profit for the first nine months of the year, taking into account the 59% dividend payout ratio of last year, our common equity ratio would have amounted to 15.9%. As already announced and in line with our dividend policy, we will pay an interim dividend of 1 euro per share on 15 November 2019 as an advance payment on the total dividend for 2019.
In the previous quarter, we had started a group-wide exercise to optimise our management governance model and, in early September, revealed the optimisation and efficiency measures for the other layers of our organisation. The goal of the exercise is to become a more agile company with a faster decision-making process, so that customer solutions can be delivered faster. As always, we plan to be respectful in how we implement the related changes for our employees. In Belgium, for instance, the related reduction in FTEs will be absorbed through natural outflow. In the Czech Republic, normal staff turnover and measures to promote the internal redeployment of staff will ensure that compulsory redundancies will also be kept to a minimum.
In September, we signed the Collective Commitment to Climate Action, an initiative of the United Nations Environmental Program Finance Initiative. By endorsing this initiative, we have committed ourselves – in cooperation with our customers – to stimulate the greening of the economy as much as possible and so limit global warming to well below 2°C, striving for 1.5°C, in line with the Paris climate agreement. In this way, we are building on previous policies and initiatives (such as phasing out the financing of coal-related activities) to help us fulfil our social role in a sustainable manner.
Ultimately, our goal is to ensure that our customers and all other stakeholders benefit from our activities, something which our employees are committed to in their day-to-day work. I would like to take this opportunity to explicitly thank
all those stakeholders who have put their trust in us to help them achieve their goals and dreams.

Johan Thijs Chief Executive Officer

Our strategy rests on four principles:


| Consolidated income statement, IFRS KBC Group (in millions of EUR) |
3Q2019 | 2Q2019 | 1Q2019 | 4Q2018 | 3Q2018 | 9M2019 | 9M2018 |
|---|---|---|---|---|---|---|---|
| Net interest income | 1 174 | 1 132 | 1 129 | 1 166 | 1 136 | 3 436 | 3 378 |
| Non-life insurance (before reinsurance) | 192 | 174 | 161 | 198 | 197 | 527 | 562 |
| Earned premiums | 440 | 425 | 415 | 409 | 403 | 1 280 | 1 173 |
| Technical charges | -248 | -251 | -254 | -211 | -205 | -753 | -611 |
| Life insurance (before reinsurance) | -5 | 1 | -3 | -3 | -9 | -7 | -15 |
| Earned premiums | 291 | 317 | 351 | 416 | 293 | 959 | 944 |
| Technical charges Ceded reinsurance result |
-297 -9 |
-316 1 |
-354 -7 |
-418 -12 |
-302 -6 |
-966 -14 |
-959 -29 |
| Dividend income | 14 | 39 | 12 | 15 | 12 | 65 | 67 |
| Net result from financial instruments at fair value through P&L1 |
-46 | -2 | 99 | 2 | 79 | 51 | 229 |
| Net realised result from debt instruments at fair value through other comprehensive income |
5 | 0 | 2 | 0 | 0 | 7 | 9 |
| Net fee and commission income | 444 | 435 | 410 | 407 | 424 | 1 289 | 1 312 |
| Net other income | 43 | 133 | 59 | 76 | 56 | 234 | 150 |
| Total income | 1 813 | 1 913 | 1 862 | 1 848 | 1 888 | 5 588 | 5 663 |
| Operating expenses | -975 | -988 | -1 296 | -996 | -981 | -3 258 | -3 239 |
| Impairment | -26 | -40 | -69 | -43 | 2 | -134 | 60 |
| Of which: on financial assets at amortised cost and at fair value through other comprehensive income2 |
-25 | -36 | -67 | -30 | 8 | -128 | 92 |
| Share in results of associated companies & joint ventures | 0 | 4 | 5 | 4 | 2 | 8 | 12 |
| Result before tax | 812 | 889 | 503 | 814 | 911 | 2 204 | 2 496 |
| Income tax expense | -200 | -144 | -73 | -192 | -211 | -417 | -548 |
| Result after tax | 612 | 745 | 430 | 621 | 701 | 1 787 | 1 949 |
| attributable to minority interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 612 | 745 | 430 | 621 | 701 | 1 787 | 1 948 |
| Basic earnings per share (EUR) Diluted earnings per share (EUR) |
1.44 1.44 |
1.76 1.76 |
0.98 0.98 |
1.44 1.44 |
1.63 1.63 |
4.19 4.19 |
4.54 4.54 |
| Key consolidated balance sheet figures KBC Group (in millions of EUR) |
30-09-2019 | 30-06-2019 | 31-03-2019 | 31-12-2018 | 30-09-2018 | ||
| Total assets | 294 830 | 289 548 | 292 332 | 283 808 | 304 740 | ||
| Loans and advances to customers, excl. reverse repos | 154 863 | 154 169 | 148 517 | 147 052 | 146 011 | ||
| Securities (equity and debt instruments) | 65 122 | 63 746 | 63 706 | 62 708 | 63 030 | ||
| Deposits from customers & debt certificates, excl. repos | 205 270 | 199 138 | 197 987 | 194 291 | 194 056 | ||
| Technical provisions, before reinsurance | 18 549 | 18 652 | 18 589 | 18 324 | 18 533 | ||
| Liabilities under investment contracts, insurance | 13 456 | 13 381 | 13 334 | 12 949 | 13 444 | ||
| Parent shareholders' equity | 18 086 | 17 799 | 17 924 | 17 233 | 16 878 | ||
| Selected ratios KBC group (consolidated) |
9M2019 | FY2018 | |||||
| Return on equity | 15%3 | 16% | |||||
| Cost/income ratio, banking (when excluding certain non-operating items and evenly spreading the bank tax) |
60% (59%) |
57.5% (57%) |
|||||
| Combined ratio, non-life insurance | 92% | 88% | |||||
| Common equity ratio, Basel III Danish Compromise (fully loaded) | 15.4%4 | 16.0% | |||||
| Common equity ratio, FICOD (fully loaded) | 14.2% | 14.9% | |||||
| Leverage ratio, Basel III (fully loaded) | 6.0% | 6.1% | |||||
| Credit cost ratio5 | 0.10% | -0.04% | |||||
| Impaired loans ratio | 3.5% | 4.3% | |||||
| for loans more than 90 days past due | 2.0% | 2.5% | |||||
| Net stable funding ratio (NSFR) | 135% | 136% | |||||
| Liquidity coverage ratio (LCR) | 140% | 139% | |||||
| 1 Also referred to as 'Trading and fair value income'. |
2 Also referred to as 'Loan loss impairment'.
3 When evenly spreading the bank tax throughout the year (14% without evenly spreading the bank tax).
4 When including the net result of the first nine months of the year, taking into account the full-year 2018 payout ratio of 59% (div. + AT1 coupon), the ratio is 15.9%.
5 A negative figure indicates a net impairment release (with a positive impact on the results).
We provide a full overview of our IFRS consolidated income statement and balance sheet in the 'Consolidated financial statements' section of the quarterly report. Condensed statements of comprehensive income, changes in shareholders' equity, as well as several notes to the accounts, are also available in the same section. As regards the (changes in) definition of ratios, see 'Details of ratios and terms' in the quarterly report.
| Total income | Total income decreased by 5% quarter-on-quarter, but that was largely related to the fact that the previous quarter had included a significant, positive one-off item in net other |
|---|---|
| 1 813 million euros |
income (related to the acquisition of the remaining stake in ČMSS). That aside, total income was down just 1% quarter-on-quarter, as the drop in trading and fair value income and the seasonal decrease in dividend income were almost fully offset by an increase in net interest income and net fee and commission income, while insurance technical income remained more or less in line with the previous quarter. |
Net interest income amounted to 1 174 million euros in the quarter under review, up 4% on the figure recorded in the previous quarter and 3% year-on-year. Net interest income benefited from the positive effect of loan volume growth, the full consolidation of ČMSS since June 2019 (resulting in one month of full consolidation in the second quarter of 2019 and three months in the third quarter of 2019; further referred to as the 'ČMSS impact'), the effect of past increases in short-term interest rates in the Czech Republic, lower customer funding costs (year-on-year) and the higher number of days in the quarter under review (compared to the previous quarter). These items were partially offset by the continued pressure on loan portfolio margins (notwithstanding some recovery in the margin of new business) and the negative effect of lower reinvestment yields in our core countries in the euro area, among other factors.
The total volume of customer lending rose slightly (0.5%) quarter-on-quarter and by as much as 6% year-on-year. On a comparable scope basis (eliminating the effects from changes in scope, including the sale of parts of the Irish loan book in the past and the full consolidation of ČMSS since June 2019), customer lending rose by 1% quarter-on-quarter and 4% year-on-year, with the latter growing in all business units. Customer deposits including debt certificates were up 3% quarter-on-quarter and 6% year-on-year. On a comparable scope basis, this item was up 3% quarter-on-quarter and 4% year-on-year. The net interest margin came to 1.94% for the quarter under review, in line with the previous quarter but down 4 basis points on the level recorded in the year-earlier quarter.
Technical income from our non-life insurance activities (earned premiums less technical charges, plus the ceded reinsurance result) contributed 184 million euros to total income. It was up 5% on the previous quarter due to a combination of higher earned premiums in all core countries, lower technical charges (lower storm-related impact and the fact that the previous quarter had been impacted by a re-assessment of claims provisions) and a lower ceded reinsurance result. Technical non-life insurance income was slightly down (-4%) on the figure recorded in the year-earlier quarter, with the increase in earned premium income being more than offset by higher technical charges and a lower ceded reinsurance result. Overall, the combined ratio for the first nine months of 2019 came to 92%, compared to 88% for full-year 2018.
Technical income from our life insurance activities was -6 million euros, compared to 0 million euros in the previous quarter and -10 million euros in the year-earlier quarter. Sales of life insurance products in the quarter under review (403 million euros) were down 12% on the level recorded in the previous quarter. Most of this decline was due to lower sales of unit-linked life insurance products in Belgium and the Czech Republic. Compared to the year-earlier quarter, however, sales of life insurance products were up 5%, driven by higher sales of both unit-linked and guaranteed interest products in Belgium. Overall, the share of guaranteedinterest products in our total life insurance sales stood at 60% in the quarter under review, with unit-linked products accounting for the remaining 40%.
At 444 million euros, net fee and commission income was up 2% on the figure recorded in the previous quarter and up by as much as 5% on the figure recorded in the year-earlier quarter. Quarter-on-quarter, net fee and commission income benefited from an increase in fees related to asset management services and in fees for banking services (mainly payment-related fees, partly a seasonal effect), as well as from the ČMSS impact, while paid distribution fees rose somewhat due chiefly to the increase in nonlife insurance sales. Compared to a year earlier, net fee and commission income benefited from an increase in fees related to banking services, slightly lower paid distribution fees and the ČMSS impact, while fee income related to asset management services was virtually unchanged. At the end of September 2019, our total assets under management stood at 212 billion euros, up 1% quarter-on-quarter, with improving asset prices (+2%, despite ongoing market unrest) more than offsetting net outflows (-1%). Year-on-year, total assets under management remained more or less unchanged, with the 4% net outflow (mainly in investment advice) being almost fully offset by a comparable price improvement.
All other remaining income items amounted to an aggregate 16 million euros, down significantly on the 170 million euros recorded in the previous quarter and the 147 million euros in the year-earlier quarter. This included a negative 46-million-euro net result from financial instruments at fair value (trading and fair value income), down on the already weak -2 million euros recorded in the previous quarter and down significantly on the 79 million euros recorded in the year-earlier quarter. The quarter's trading and fair value income was negatively impacted mainly by poor dealing room income and the aggregate negative impact of various market value adjustments. The other remaining income items also included seasonally lower dividend income of 14 million euros (down on the 39 million euros recorded in the second quarter of the year when the bulk of dividends is usually received), a 5-million-euro net realised result from debt instruments at fair value through other comprehensive income and 43 million euros in net other income. The figure for net other income came to 56 million euros in the year-earlier quarter and to 133 million euros in the previous quarter, which had benefited from a one-off 82-million-euro gain related to the revaluation of the existing stake in ČMSS that was triggered by the acquisition of the remaining participation in that company. It should be noted that the largest one-off item included in net other income in the quarter under review was an 18-million-euro charge related to the tracker mortgage review in Ireland (14 million euros of which relating to a provision for a potential sanction).
Operating expenses Operating expenses in the third quarter were down 1% compared to the previous quarter. When certain non-operating items are excluded and bank taxes evenly spread throughout the year, the cost/income ratio for the nine-month period amounted to 59%. 975 million euros
Operating expenses in the third quarter of 2019 stood at 975 million euros. Excluding bank taxes, operating expenses fell by 1%, both quarter-on-quarter and year-on-year. In both cases, the difference is accounted for by a number of factors, including lower staff costs (despite wage inflation in most countries), higher depreciation costs, the effect of the full consolidation of ČMSS since June 2019 and a number of one-off items in the current and reference quarters.
When certain non-operating items are excluded and the bank tax evenly spread throughout the year, the cost/income ratio of our banking activities came to 59% for the first nine months of 2019, compared to 57% for full-year 2018. Including the non-operating items and the bank taxes actually recorded, the cost/income ratio of our banking activities stood at 60% year-to-date.
| Net loan loss impairment charge of 25 million euros, down on the 36 million euros Loan loss impairment recorded in the previous quarter. Benign credit cost ratio of 0.10% for the first nine 25-million-euro net increase months of the year. |
|
|---|---|
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | -- |
In the third quarter of 2019, we recorded a 25-million-euro net impairment charge, compared with a net charge of 36 million euros in the previous quarter and a net release of 8 million euros in the third quarter of 2018. Most of the net impairment charge in the third quarter of 2019 related to files in the corporate segment. Broken down by country, loan loss impairment charges in the third quarter of 2019 came to 21 million euros in Belgium, 9 million euros in the Czech Republic, 6 million euros in Slovakia, 1 million euros in Hungary and 6 million euros in Bulgaria, while there were net impairment releases of 7 million euros in Ireland and 10 million euros in the Group Centre. For the entire group, the credit cost ratio amounted to 0.10% for the first nine months of the year, compared to -0.04% for full-year 2018 (a negative figure indicates a net release and, hence, has a positive effect on the results).
The impaired loans ratio has continued to improve since the start of the year. At the end of September 2019, some 3.5% of our total loan book was classified as impaired (4.3% at year-end 2018). Impaired loans that are more than 90 days past due fell to 2.0% of the loan book (2.5% at year-end 2018). The drop in impaired loans is partly related to the accounting write-off of certain fully provisioned legacy loans in Ireland in the past quarters.
Impairment on assets other than loans stood at 1 million euros, compared to 4 million euros in the previous quarter and 6 million euros in the third quarter of 2018.
| Net result | Belgium | Czech Republic | International Markets | Group Centre |
|---|---|---|---|---|
| by business unit | 368 million euros | 159 million euros | 85 million euros | 0 million euros |
Belgium: the net result (368 million euros) was down 5% quarter-on-quarter. The third quarter result included higher interest income, improved technical insurance results, seasonally lower dividend income, significantly lower trading and fair value income, slightly higher net fee and commission income, and lower costs and loan loss impairment charges.
Czech Republic: the net result (159 million euros) was down 36% on its level for the previous quarter, since that quarter had included a one-off revaluation gain of 82 million euros on the existing 55% participation in ČMSS following the acquisition of the remaining 45% stake. Excluding that item, the net result was down 4%, which was due mainly to lower trading and fair value income, partly offset by higher net interest income.
International Markets: the 85-million-euro net result breaks down as follows: 12 million euros in Slovakia, 45 million euros in Hungary, 23 million euros in Bulgaria and 4 million euros in Ireland. For the business unit as a whole, the net result was down 18% quarter-on-quarter, due mainly to Bulgaria and Hungary (partly as a result of higher loan loss impairments in both countries) and Ireland (where the positive effect of a decrease in costs and the net release of loan loss provisions was more than offset by a negative one-off item related to the tracker mortgage review).
Group Centre: the net result (0 million euros) was down 4 million euros quarter-on-quarter. The quarter under review benefited from higher trading and fair value income and a higher release of loan loss provisions, among other things, but this performance was more than offset by the fact that the previous quarter had benefited from a significant positive one-off item in the tax line.
| Belgium | Czech Republic | International Markets | ||||
|---|---|---|---|---|---|---|
| Selected ratios by business unit | 9M2019 | FY2018 | 9M2019 | FY2018 | 9M2019 | FY2018 |
| Cost/income ratio, banking excluding certain non-operating items and spreading the bank tax evenly |
58% | 58% | 47% | 46% | 68% | 65% |
| Combined ratio, non-life insurance | 91% | 87% | 94% | 97% | 88% | 90% |
| Credit cost ratio* | 0.16% | 0.09% | 0.05% | 0.03% | 0.02% | -0.46% |
| Impaired loans ratio | 2.3% | 2.6% | 2.3% | 2.4% | 9.1% | 12.2% |
* A negative figure indicates a net impairment release (positively affecting results). See 'Details of ratios and terms' in the quarterly report.
A full results table is provided in the 'Additional information' section of the quarterly report. A short analysis of the results per business unit is provided in the analyst presentation (available at www.kbc.com).
| Equity, solvency | Total | Common equity | Liquidity coverage | Net stable funding | |
|---|---|---|---|---|---|
| and | equity | ratio (fully loaded) | ratio | ratio | |
| liquidity | 19.6 billion euros | 15.4% | 140% | 135% |
At the end of September 2019, total equity stood at 19.6 billion euros, comprising 18.1 billion euros in parent shareholders' equity and 1.5 billion euros in additional tier-1 instruments. Total equity was more or less unchanged on its level at the end of 2018, owing to the combined effect of a number of items, including profits for the nine-month period (+1.8 billion euros), the call of an additional tier-1 instrument and issuance of a new additional tier-1 instrument (-1.4 billion euros and +0.5 billion euros, respectively), payment of the final dividend for 2018 in May 2019 and the decision to pay an interim dividend for 2019 in November 2019 (-1.0 billion euros and -0.4 billion euros, respectively) and changes in various revaluation reserves (an aggregate +0.6 billion euros). We have provided details of the changes in the 'Consolidated financial statements' section of the quarterly report (under 'Consolidated statement of changes in equity').
Our common equity ratio at 30 September 2019 amounted to 15.4%, without recognition of the net profit for the first nine months of 2019. When we include the IFRS net profit for that period, taking into account the payout ratio of 59% (dividend + AT1 coupon) for full-year 2018, the common equity ratio amounted to 15.9% at the end of September 2019, compared to 16% at the end of 2018. Our leverage ratio (Basel III, fully loaded) came to 6.0%. The solvency ratio for KBC Insurance under the Solvency II framework was a sound 187% at the end of September 2019. Our liquidity position remained excellent too, as reflected in an LCR ratio of 140% and an NSFR ratio of 135% at 30 September.
| Net result | The net result for the first nine months of 2019 was down 8% compared to the corresponding period of 2018. Total income was more or less in line with the year-earlier |
|---|---|
| 1 787 million euros |
period, with the increase in net interest income and net other income (due to the one-off gain related to the acquisition of the remaining stake in ČMSS) almost fully offsetting the decrease in the other income lines. Costs remained strictly under control, with the full 1% increase being accounted for by higher bank taxes. Loan loss impairment charges amounted to 128 million euros, significantly higher than the net impairment release of 92 million euros in the year-earlier period. |
Highlights (compared to the first nine months of 2018):
• Somewhat higher net interest income (up 2% to 3 436 million euros), due to inter alia lower funding costs, higher commercial lending volumes, the positive impact of short-term rate increases in the Czech Republic and the ČMSS impact, which offset pressure on portfolio margins, the negative effects of lower reinvestment yields in our core euro-area countries and the lower netted positive impact of ALM FX swaps. The volume of deposits and debt certificates was up 4%, and lending volumes increased by 4% as well, with growth in all business units. These volume figures have been calculated on a comparable scope basis. The net interest margin in the first nine months of 2019 came to 1.95%, down 5 basis points year-on-year.
As we are mainly active in banking, insurance and asset management, we are exposed to a number of typical risks for these financial sectors such as – but not limited to – credit default risk, counterparty credit risk, concentration risk, movements in interest rates, currency risk, market risk, liquidity and funding risk, insurance underwriting risk, changes in regulations, operational risk, customer litigation, competition from other and new players, as well as the economy in general. KBC closely monitors and manages each of these risks within a strict risk framework, but they may all have a negative impact on asset values or could generate additional charges beyond anticipated levels.
At present, a number of items are considered to constitute the main challenges for the financial sector. These relate to recent macroeconomic and political developments, such as Brexit and trade conflicts, all of which affect global and European economies, including KBC's home markets. Economic growth and interest rate forecasts have been lowered, making it increasingly likely that the low interest rate environment will persist for longer than originally anticipated. Regulatory and compliance risks (including antimoney laundering regulations and GDPR) remain a dominant theme for the sector, as does enhanced consumer protection. Digitalisation (with technology as a catalyst) presents both opportunities and threats to the business model of traditional financial institutions, while climate-related risks are becoming increasingly prevalent. Finally, cyber risk has become one of the main threats during the past few years, not just for the financial sector, but for the economy as a whole.
We provide risk management data in our annual reports, quarterly reports and dedicated risk reports, all of which are available at www.kbc.com.
A weaker economic outlook with elevated risks and below-target inflation levels have led to a shift in major central banks' forward guidance towards additional or renewed monetary stimuli. Following the rate cuts earlier this year, we expect the Fed to keep its policy rate constant this year and the next year. Since euro-area inflation will remain below the ECB's medium-term target and risk factors, such as trade conflicts, are negatively impacting the momentum of European growth, the ECB will most likely keep monetary policy very accommodative in the years to come.
Flight-to-quality and safe-haven effects, subdued European (core) inflation and, in particular, a dovish ECB will continue to limit the upward potential for longer-term interest rates and intra-EMU sovereign spreads.
The Czech National Bank (CNB) tightened its monetary policy with a somewhat sooner-than-expected rate hike earlier this year (+25 basis points to 2% on 2 May), reflecting an environment of buoyant Czech growth and inflation.
In line with global economic developments, the European economy is currently slowing down. Decreasing unemployment rates and growing labour shortages in some European economies, combined with solid wage inflation, are likely to continue underpinning private consumption. Investment is also likely to remain supportive for growth. The main factors that could substantially impede European economic sentiment and growth remain the risk of further economic deglobalisation, including an escalation of trade conflicts, Brexit and political turmoil in some euro-area countries.
| assets (RWA) by roughly 8 billion euros (on a fully loaded basis at the end of 2018), corresponding to RWA inflation of 9% and an impact on the common equity ratio of -1.3 |
Guidance | • Solid returns for all business units. • Basel IV impact (as of 1 January 2022) for KBC is estimated to increase risk-weighted percentage points. |
|
|---|---|---|---|
| -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | -- | ---------- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Upcoming events | Interim dividend payment: 15 November 2019 4Q2019 results: 13 February 2020 Annual report: 3 April 2020 Annual General Meeting: 7 May 2020 1Q2020 results: 14 May 2020 |
|---|---|
| More information on 3Q2019 |
Quarterly report: www.kbc.com / Investor Relations / Reports Company presentation: www.kbc.com / Investor Relations / Presentations |
| Definitions of ratios |
'Details of ratios and terms at KBC Group level' in the last section of the quarterly report. |
Consolidated financial statements according to IFRS

Section reviewed by the Auditor
AC: amortised cost AFS: Available For Sale (IAS 39) ALM: Asset Liability Management ECL: Expected Credit Loss FA: Financial Assets FV: Fair Value FVA: Funding Value Adjustment FVOCI: Fair Value through Other Comprehensive Income FVPL: Fair Value through Profit or Loss FVPL – overlay: Fair Value through Profit or Loss - overlay GCA: Gross Carrying Amount HFT: Held For Trading OCI: Other Comprehensive Income POCI: Purchased or Originated Credit Impaired Assets SPPI: Solely payments of principal and interest SRB: Single Resolution Board R/E: Retained Earnings
| (in millions of EUR) | Note | 9M 2019 | 9M 2018 | 3Q 2019 | 2Q 2019 | 3Q 2018 |
|---|---|---|---|---|---|---|
| Net interest income | 3.1 | 3 436 | 3 378 | 1 174 | 1 132 | 1 136 |
| Interest income | 3.1 | 5 435 | 5 148 | 1 806 | 1 807 | 1 754 |
| Interest expense | 3.1 | - 1 999 | - 1 771 | - 632 | 675 - |
618 - |
| Non-life insurance (before reinsurance) | 3.7 | 527 | 562 | 192 | 174 | 197 |
| Earned premiums | 3.7 | 1 280 | 1 173 | 440 | 425 | 403 |
| Technical charges | 3.7 | - 753 | - 611 | - 248 | 251 | 205 |
| Life insurance (before reinsurance) | 3.7 | - 7 | - 15 | - 5 | 1 | - 9 |
| Earned premiums | 3.7 | 959 | 944 | 291 | 317 | 293 |
| Technical charges | 3.7 | - 966 | - 959 | - 297 | 316 | 302 |
| Ceded reinsurance result | 3.7 | - 14 | 29 | - 9 | 1 | - 6 |
| Dividend income | 65 | 67 | 14 | રૂત્વે | 12 | |
| Net result from financial instruments at fair value through profit or loss | 3.3 | 51 | 229 | 46 | - 2 | 79 |
| of which result on equity instruments (overlay approach) | 65 | 54 | 17 | 19 | 2 | |
| Net realised result from debt instruments at fair value through OCI | 7 | 9 | 5 | 0 | 0 | |
| Net fee and commission income | 3.5 | 1 289 | 1 312 | 444 | 435 | 424 |
| Fee and commission income | 3.5 | 1 833 | 1 853 | 629 | 616 | ୧୦୧ |
| Fee and commission expense | 3.5 | - 543 | - 541 | - 185 | - 180 | 182 l |
| Net other income | 3.6 | 234 | 150 | 43 | 133 | 56 |
| TOTAL INCOME | 5 588 | 5 663 | 1 813 | 1 913 | 1 888 | |
| Operating expenses | 3.8 | - 3 258 | - 3 239 | - 975 | 088 । |
- 981 |
| Staff expenses | 3.8 | - 1 755 | - 1 763 | - 585 | 603 | 593 l |
| General administrative expenses | 3.8 | - 1 244 | - 1 269 | - 299 | 298 | 318 - |
| Depreciation and amortisation of fixed assets | 3.8 | - 260 | - 207 | - 90 | 87 | 70 - |
| Impairment | 3.10 | - 134 | 60 | - 26 | - 40 | 2 |
| on financial assets at AC and at FVOCI | 3.10 | - 128 | 92 | 25 | 36 | 8 |
| on goodwill | 3.10 | 0 | 0 | 0 | 0 | 0 |
| other | 3.10 | 6 - |
32 | 1 - |
4 - |
ഗ |
| Share in results of associated companies and joint ventures | 8 | 12 | 0 | 4 | 2 | |
| RESULT BEFORE TAX | 2 204 | 2 496 | 812 | 889 | 911 | |
| Income tax expense | 3.12 | - 417 | - 548 | - 200 | - 144 | 211 l |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| RESULT AFTER TAX | 1 787 | 1 949 | 612 | 745 | 701 | |
| attributable to minority interests | 0 | 0 | 0 | 0 | O | |
| of which relating to discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| attributable to equity holders of the parent | 1 787 | 1 948 | 612 | 745 | 701 | |
| of which relating to discontinued operations | 0 | 0 | 0 | 0 | 0 | |
| Earnings per share (in EUR) | ||||||
| Ordinary | 4.19 | 4.54 | 1.44 | 1.76 | 1.63 | |
| Diluted | 4.19 | 4.54 | 1.44 | 1.76 | 1.63 |
As of June 2019 the result of Czech building savings bank Českomoravská stavební spořitelna (ČMSS) is fully consolidated, while previously according to the equity method. For more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report.
The equity instruments of the insurance companies within the group are designated under the overlay approach. These equity instruments, mainly classified as AFS under IAS 39, would have been measured at fair value through P&L under IFRS 9. The overlay approach reclassifies from the income statement to OCI the extra volatility related to the adoption of IFRS 9 as long as IFRS 17 is not in place, until 1st January 2022 (subject to EU endorsement).
The extra volatility due to IFRS 9, reclassified out of the net result from financial instruments at fair value through profit or loss to the revaluation reserves of equity instruments (overlay approach) refers to the unrealised fair value fluctuations amounting to 150 million euros in 9M 2019. It can be summarized as the difference between
| (in millions of EUR) | 9M 2019 | 9M 2018 | 3Q 2019 | 2Q 2019 | 3Q 2018 |
|---|---|---|---|---|---|
| RESULT AFTER TAX | 1 787 | 1 949 | 612 | 745 | 701 |
| attributable to minority interests | 0 | 0 | 0 | O | 0 |
| attributable to equity holders of the parent | 1 787 | 1 948 | 612 | 745 | 701 |
| OCI TO BE RECYCLED TO PROFIT OR LOSS | 559 | - 266 | 93 | 222 | - 25 |
| Net change in revaluation reserve (FVOCI debt instruments) | 658 | 242 | 239 | 226 | - 104 |
| Net change in revaluation reserve (FVPL equity instruments) - overlay | 150 | 61 | 11 | 17 | 14 |
| Net change in hedging reserve (cashflow hedges) | 173 | 69 | 73 | 35 | 52 |
| Net change in translation differences | - 86 | 78 l |
81 | 2 | 58 |
| Hedge of net investments in foreign operations | 8 | 55 | 2 - |
8 | 42 |
| Net change in respect of associated companies and joint ventures | 6 | 6 l |
4 | 4 | 0 |
| Other movements | 3 - |
3 | 5 - |
0 | 3 |
| OCI NOT TO BE RECYCLED TO PROFIT OR LOSS | 3 | 25 | 7 | 37 l |
37 |
| Net change in revaluation reserve (FVOCI equity instruments) | 16 | 9 | 5 | 4 | ব |
| Net change in defined benefit plans | 12 । |
15 | - 43 | 34 | |
| Net change in own credit risk | - | 1 | 0 | ||
| Net change in respect of associated companies and joint ventures | 0 | 0 | 0 | 0 | |
| TOTAL COMPREHENSIVE INCOME | 2 349 | 1 708 | 712 | 930 | 713 |
| attributable to minority interests | 0 | 0 | 0 | O | 0 |
| attributable to equity holders of the parent | 2 349 | 1 707 | 711 | 930 | 713 |
The largest movements in other comprehensive income (9M 2019 vs. 9M 2018):
Net change in translation differences in 9M 2018 (-78 million euros) is also mainly caused by the weakening of the CZK and HUF versus the EUR. This was largely compensated by the hedge of net investment in foreign operations (+55 million euros), as the hedge in 2018 was still based on the old hedging policy. The net impact between these two items can mainly be explained by the asymmetrical deferred tax treatment (no tax on net change in translation differences, while deferred tax is calculated on the hedge).
| (in millions of EUR) | Note 30-09-2019 31-12-2018 | ||
|---|---|---|---|
| ASSETS | |||
| Cash, cash balances with central banks and other demand deposits with credit institutions | 7 758 | 18 691 | |
| Financial assets | 4.0 | 277 544 | 256 916 |
| Amortised cost | 4.0 | 233 090 | 216 792 |
| Fair value through OCI | 4.0 | 19 356 | 18 279 |
| Fair value through profit or loss | 4.0 | 24 915 | 21 663 |
| of which held for trading | 4.0 | 8 915 | 6 426 |
| Hedging derivatives | 4.0 | 184 | 183 |
| Reinsurers' share in technical provisions, insurance | 131 | 120 | |
| Fair value adjustments of the hedged items in portfolio hedge of interest rate risk | 930 | 64 | |
| Tax assets | 1 506 | 1 549 | |
| Current tax assets | 106 | 92 | |
| Deferred tax assets | 1 400 | 1 457 | |
| Non-current assets held for sale and disposal groups | 0 | 14 | |
| Investments in associated companies and joint ventures | 62 | 215 | |
| Property, equipment and investment property | 3 752 | 3 299 | |
| Goodwill and other intangible assets | 1 567 | 1 330 | |
| Other assets | 1 580 | 1 610 | |
| TOTAL ASSETS | 294 830 | 283 808 | |
| LIABILITIES AND EQUITY | |||
| Financial liabilities | 4.0 | 252 719 | 242 626 |
| Amortised cost | 4.0 | 228 250 | 220 671 |
| Fair value through profit or loss | 4.0 | 23 099 | 20 844 |
| of which held for trading | 4.0 | 7 134 | 5 834 |
| Hedging derivatives | 4.0 | 1 371 | 1 111 |
| Technical provisions, before reinsurance | 18 549 | 18 324 | |
| Fair value adjustments of the hedged items in portfolio hedge of interest rate risk | 7 | - 79 | |
| Tax liabilities | 487 | 380 | |
| Current tax liabilities | 56 | 133 | |
| Deferred tax liabilies | 431 | 247 | |
| Liabilities associated with disposal groups | O | O | |
| Provisions for risks and charges | 217 | 235 | |
| Other liabilities | 3 265 | 2 689 | |
| TOTAL LIABILITIES | 275 245 | 264 175 | |
| Total equity | 5.10 | 19 585 | 19 633 |
| Parent shareholders' equity | 5.10 | 18 086 | 17 233 |
| Additional tier-1 instruments included in equity | 5.10 | 1 500 | 2 400 |
| Minority interests | O | O | |
| TOTAL LIABILITIES AND EQUITY | 294 830 | 283 808 |
As of June 2019 the balance sheet contains figures of the Czech building savings bank Českomoravská stavební spořitelna (ČMSS), of which the remaining 45% stake was acquired in May 2019 resulting in full consolidation (before: equity method). For more information see note 'Main changes in the scope of consolidation' (note 6.6) further in this report.
| (in millions of EUR) | Issued and paid up share capital premium shares earnings |
Share Treasury Retained | Revaluation reserve (AFS assets) |
Revaluation reserve (FVOCI debt instruments) |
Revaluation reserve (FVPL equity instruments) - overlay |
Revaluation reserve (FVOCI equity instruments) |
Hedging reserve (cashflow hedges) |
differences | Hedge of net foreign operations |
Re- Translation investments in measurement of defined benefit plans |
Own credit risk through OCI |
Total revaluation reserves |
Parent shareholders' instruments equity |
Additional tier-1 included in equity |
Minority interests |
Total equity |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30-09-2019 | ||||||||||||||||||
| Balance at the end of the previous period | 1 457 | 5 482 | - 3 10 901 | 586 | 159 | 22 | - 1 263 | - 73 | 86 | - 119 | - 3 | - 605 | 17 233 | 2 400 | 0 | 19 633 | ||
| Net result for the period | 0 | 0 | 0 | 1 787 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 787 | 0 | 0 | 1 787 | |
| Other comprehensive income for the period | 0 | 0 | O | - 3 | 665 | 150 | 16 | - 173 | - 87 | 8 | - 12 | - 1 | 565 | 562 | 0 | 0 | 562 | |
| Subtotal | 0 | 0 | 0 | 1 783 | 665 | 150 | 16 | - 173 | - 87 | 8 | - 12 | - 1 | રકાર | 2 349 | 0 | C | 2 349 | |
| Dividends | 0 | 0 | 0 - 1 457 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 1 457 | 0 | 0 | - 1 457 | ||
| Coupon on AT1 | 0 | 0 | 0 | - 37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 37 | 0 | 0 | - 37 | |
| Issue or Call of AT1 included in equity | 0 | 0 | O | - 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 2 | 900 - |
0 | - 902 | |
| Purchase/sale of treasury shares | 0 | 0 | O | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total change | 0 | O | 287 | 665 | 150 | 16 | - 173 | - 87 | 8 | - 12 | - 1 | 565 | 853 | 900 | 0 | - 47 | ||
| Balance at the end of the period | 1 457 | 5 482 | - 2 11 188 | 1 250 | 309 | 38 | - 1 436 | - 160 | 94 | - 131 | - 5 | - 39 | 18 086 | 1 500 | 0 | 19 585 | ||
| of which relating to the equity method | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 13 | 13 | ||||||||
| 2018 | ||||||||||||||||||
| Balance at the end of the previous period | 1 456 | 5 467 | - 5 10 101 | 1 751 | 0 | 0 | 0 | - 1 339 | - 11 | 45 | - 52 | - 10 | 383 | 17 403 | 1 400 | 0 | 18 803 | |
| Impact of the first-time adoption of IFRS 9 | 0 | 0 | 0 | - 247 | - 1 751 | 837 | 387 | 29 | 0 | 0 | 0 | 0 | 0 | - 499 | - 746 | 0 | 0 | - 746 |
| Balance at the beginning of the period after impact IFRS 9 | 1 456 | 5 467 | - 5 | 9 854 | 0 | 837 | 387 | 29 | - 1 339 | - 11 | 45 | - 52 | - 10 | - 116 | 16 657 | 1 400 | 0 | 18 057 |
| Net result for the period | 0 | 0 | 0 | 2 570 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 570 | 0 | 0 | 2 570 |
| Other comprehensive income for the period | 0 | 0 | 0 | - 2 | 0 | - 251 | - 228 | - 6 | 76 | - 61 | 41 | - 67 | - 489 | - 491 | 0 | 0 | - 491 | |
| Subtotal | 0 | 0 | 0 | 2 568 | 0 | - 251 | - 228 | - 6 | 76 | - 61 | 41 | - 67 | 7 | - 489 | 2 079 | 0 | 0 | 2 079 |
| Dividends | 0 | 0 | o | - 1 253 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 1 253 | 0 | 0 | - 1 253 |
| Coupon on AT1 | 0 | 0 | 0 | - 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 70 | 0 | 0 | - 70 |
| Capital increase | 1 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 16 |
0 | 0 | 16 | |
| Transfer from revaluation reserves to retained earnings on realisation |
0 | 0 | 0 | - 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 12 | 0 | 0 | - 12 |
| Issue of AT1 included in equity | 0 | 0 | 0 | - 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 5 | 1 000 | 0 | વેવે ર |
| Purchase/sale of treasury shares | 0 | 0 | - 179 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 179 | 0 | 0 | - 179 |
| Liquidation of treasury shares | 0 | 0 | 181 | - 181 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | O | 0 | 0 |
| Total change | 1 | 15 | 2 | 1 047 | 0 | - 251 | - 228 | - 6 | 76 | - 61 | 41 | - 67 | 7 | - 489 | 576 | 1 000 | 0 | 1 576 |
| Balance at the end of the period | 1 457 | 5 482 | - 3 10 901 | 0 | 586 | 159 | 22 | - 1 263 | - 73 | 86 | - 119 | - 3 | - 605 | 17 233 | 2 400 | 0 | 19 633 | |
| of which relating to the equity method | 0 | 5 | 0 | 0 | 14 | 0 | 0 | 0 | 20 | 20 | 20 |
The line 'Dividends' in 9M 2019 includes:
The line 'Issue or Call of additional Tier-1 instruments included in equity' in 9M 2019 includes:
| (in millions of EUR) | Issued and paid up share capital premium shares earnings |
Share Treasury Retained | Revaluation reserve (AFS assets) |
Revaluation reserve (FVOCI debt instruments) |
Revaluation reserve (FVPL equity instruments) - overlay |
Revaluation reserve (FVOCl equity, instruments) |
Hedging reserve (cashflow hedges) |
differences . | Hedge of net foreign |
Re- Translation investments in measurement of defined operations benefit plans |
Own credit risk through OCI |
Total revaluation reserves |
Parent shareholders' instruments equity |
Additional tier-1 included in equity |
Minority interests |
Total equity |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30-09-2018 | ||||||||||||||||||
| Balance at the end of the previous period | 1 456 | 5 467 | - 5 10 101 | 1 751 | 0 | 0 | 0 | - 1 339 | - 11 | 45 | - 52 | - 10 | 383 | 17 403 | 1 400 | 18 803 | ||
| Impact of the first-time adoption of IFRS 9 | - 247 | - 1 751 | 837 | 387 | 29 | 0 | - 499 | - 746 | O | - 746 | ||||||||
| Balance at the beginning of the period after impact IFRS 9 | 1 456 | 5 467 | - 5 | 9 854 | 0 | 837 | 387 | 29 | - 1 339 | - 11 | 45 | - 52 | - 10 | - 116 | 16 657 | 1 400 | O | 18 057 |
| Net result for the period | 0 | o | 1 948 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 948 | 0 | 0 | 1 949 | ||
| OCI for the period | - 3 | 0 | - 246 | - 61 | ea | - 80 - | રક | 15 | 238 | - 241 | 0 | - 241 | ||||||
| Subtotal | O | 1 945 | 0 | - 246 | - 61 | 69 | - 80 | 55 | 15 | - 238 | 1 707 | 0 | O | 1 707 | ||||
| Dividends | 0 | o | - 1 253 | 0 | 0 | 0 | 0 | 0 | () | 0 | 0 | 0 | 0 | - 1 253 | 0 | C | - 1 253 | |
| Coupon on AT1 | 0 | - 42 | 0 | 0 | 0 | 0 | 0 | 0 | - 42 | 0 | O | - 42 | ||||||
| Transfer from revaluation reserves to retained earnings on realisation |
- 8 | 0 | 0 | 0 | 0 | 0 | 0 | - 8 | 0 | O | - 8 | |||||||
| Issue of AT1 included in equity | 0 | - 5 | 0 | O | 0 | 0 | 0 | 0 | 0 | - 5 | 1 000 | O | 995 | |||||
| Purchase/sale of treasury shares | o | - 180 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 180 | 0 | O | - 180 | |||||
| Liquidation of treasury shares | 181 | 181 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
| Total change | 458 | 0 | - 246 | - 61 | 69 | - 80 | 55 | 15 | 238 | 221 | 1 000 | 1 221 | ||||||
| Balance at the end of the period | 1 456 | - 4 10 312 | 0 | 590 | 326 | 37 | - 1 270 | - 92 | 100 | - 37 | - 9 | - 354 | 16 878 | 2 400 | 19 278 | |||
| of which relating to application of the equity method | 6 | 0 | 14 | 20 | 20 | 20 |
The line 'Dividends' in 2018 includes:
The line 'Liquidation of treasury shares' in 2018 includes:
• a total number of 2 700 000 of own shares were bought under the share buy-back program for a total amount of 181 million euros, which were subsequently cancelled.
| (in millions of EUR) | 9M 2019 | 9M 2018 |
|---|---|---|
| Cash and cash equivalents at the beginning of the period | 34 354 | 40 413 |
| Net cash from (used in) operating activities | - 5 539 | 6 398 |
| Net cash from (used in) investing activities | 169 | 3 319 |
| Net cash from (used in) financing activities | 152 | - 16 |
| Effects of exchange rate changes on opening cash and cash equivalents | - 127 | - 178 |
| Cash and cash equivalents at the end of the period | 29 009 | 49 936 |
The negative net cash from operating activities in 9M 2019 mainly includes the repayment of a part (4 billion euros) of the outstanding TLTRO II in combination with higher term loans and mortgage loans, partly compensated by higher certificates of deposit and the realized result.
The positive net cash from operating activities in 9M 2018 is mainly thanks to the realized result and lower outstanding debt securities at fair value through OCI (versus year-end 2017).
Net cash from (used in) investing activities of 9M 2019 includes +439 million euros related to the acquisition of the remaining 45% stake in the Czech building society Českomoravská stavební spořitelna (ČMSS) (the acquisition price of 240 million euros is more than compensated by available cash and cash equivalents on the balance sheet of ČMSS) being partly offset by additional investments in debt securities at amortised cost. The net cash from (used in) investing activities of 9M 2018 is related to maturing investments in debt securities at amortised cost.
The net cash flow from financing activities in 9M 2019 includes (for more information see 'Parent shareholders' equity and AT1 instruments' (note 5.10) further in this report):
The net cash flow from financing activities in 9M 2018 includes:
The condensed interim financial statements of the KBC Group for the period ended 30 September 2019 have been prepared in accordance with IAS 34, 'Interim financial reporting'. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2018, which have been prepared in accordance with the International Financial Reporting Standards as adopted for use in the European Union ('endorsed IFRS').
The following IFRS standards became effective on 1 January 2019 and have been applied in this report:
The following IFRS standards were issued but not yet effective in 2019. KBC will apply these standards when they become mandatory.
A summary of the main accounting policies is provided in the group's annual accounts as at 31 December 2018.
For a description on the management structure and linked reporting presentation, reference is made to note 2.1 in the annual accounts 2018.
| (in millions of EUR) | Belgium Business unit |
Czech Republic Business unit |
International Markets Business unit |
Of which: | Hungary Slovakia Bulgaria Ireland | Group Centre |
КВС Group |
||
|---|---|---|---|---|---|---|---|---|---|
| 9M 2019 | |||||||||
| Net interest income | 1 882 | 839 | 644 | 190 | 153 | 105 | 196 | - 29 | 3 436 |
| Non-life insurance (betore reinsurance) | 334 | 85 | 102 | 34 | 21 | 47 | 0 | 6 | 527 |
| Earned premiums | 829 | 208 | 235 | 109 | 35 | 92 | 0 | 8 | 1 280 |
| Technical charges | - 496 | - 123 | - 133 | - 75 | - 14 | 44 - |
0 | - 2 | - 753 |
| Life insurance (before reinsurance) | - 74 | 42 | 25 | 6 | 8 | 17 | 0 | 0 | - 7 |
| Earned premiums | 718 | 170 | 71 | 12 | 31 | 28 | 0 | 0 | 959 |
| Technical charges | - 792 | - 128 | - 46 | - 7 | - 23 | - 17 | 0 | 0 | - 966 |
| Ceded reinsurance result | 1 | - 5 | - 8 | - 2 | - 1 | - 5 | 0 | - 9 | - 14 |
| Dividend income | 63 | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 65 |
| Net result from financial instruments at fair value through profit or loss | 88 | - 93 | 25 | 24 | - 7 | 11 | 3 - |
31 | 51 |
| Net realised result from debt instruments at fair value through OCI | 5 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 7 |
| Net fee and commission income | 875 | 195 | 222 | 158 | 48 | 18 | - 2 | - 3 | 1 289 |
| Net other income | 146 | ਰੇਰੇ | - 15 | 1 | 5 | 0 | - 22 | 5 | 234 |
| TOTAL INCOME | 3 326 | 1 263 | 997 | 412 | 229 | 189 | 168 | 2 | 5 588 |
| Operating expenses | - 1 935 | - 570 | - 685 | - 267 | - 158 | - 106 | - 154 | - 69 | - 3 258 |
| Impairment | - 136 | - 14 | - 5 | 2 | - 16 | - 9 | 18 | 21 | = 134 |
| on financial assets at amortised cost and at fair value through OCI | - 134 | - 11 | - 4 | 3 | - 16 | - 8 | 18 | 21 | - 128 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other | - 2 | - 3 | - 1 | 1 - |
0 | - 1 | 0 | 0 | 6 - |
| Share in results of associated companies and joint ventures | - 4 | 9 | 4 | 0 | 0 | 0 | 0 | 0 | 8 |
| RESULT BEFORE TAX | 1 251 | 687 | 311 | 147 | 54 | 73 | 33 | - 46 | 2 204 |
| Income tax expense | - 319 | - 103 | - 51 | - 24 | - 13 | - 8 | - 7 | 56 | - 417 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | O |
| RESULT AFTER TAX | 932 | 584 | 260 | 124 | 41 | 66 | 27 | 10 | 1 787 |
| attributable to minority interests | 0 | O | O | 0 | 0 | 0 | 0 | 0 | 0 |
| attributable to equity holders of the parent | 932 | 584 | 260 | 124 | 41 | 66 | 27 | 10 | 1 787 |
| 9M 2018 | |||||||||
| Net interest income | 1 928 | 752 | 674 | 180 | 158 | 114 | 222 | 23 | 3 378 |
| Non-life insurance (before reinsurance) | 386 | 77 | 89 | 31 | 18 | 39 | 0 | 10 | 562 |
| Earned premiums | 795 | 184 | 187 | 81 | 30 | 75 | 0 | 7 | 1 173 |
| Technical charges | - 410 | - 106 | - 98 | 50 - |
- 12 | 36 - |
O | 3 | - 611 |
| Life insurance (before reinsurance) | - 81 | 44 | 22 | 6 | 9 | 7 | 0 | 0 | = 15 |
| Earned premiums | 689 | 181 | 74 | 12 | 40 | 22 | 0 | 0 | 944 |
| Technical charges | - 770 | - 138 | - 52 | - 6 | 31 - |
- 15 | 0 | 1 | - 959 |
| Ceded reinsurance result | - 15 | - 5 | - 9 | 2 - |
- 2 | - 5 | 0 | 0 | - 29 |
| Dividend income | 61 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 67 |
| Net result from financial instruments at fair value through profit or loss | 141 | ୧୫ | 66 | 49 | 6 | 9 | 2 | - 46 | 229 |
| Net realised result from debt instruments at fair value through OCI | 0 | 0 | 0 | - 1 | 0 | 1 | 0 | 9 | 9 |
| Net fee and commission income | 808 | 193 | 214 | 147 | 44 | 23 | 0 | - 3 | 1 312 |
| Net other income | 152 | 10 | 18 | 15 | 5 | - 2 | - 1 | - 29 | 150 |
| TOTAL INCOME | 3 481 | 1 139 | 1 075 | 427 | 240 | 186 | 223 | 32 | 5 663 |
| Operating expenses | - 1 943 | - 542 | - 676 | 262 - |
- 152 | 108 - |
- 153 | - 78 | - 3 239 |
| Impairment | - 44 | - 32 | 111 | 7 | 1 | 7 | તે રેણ | 24 | 60 |
| on financial assets at amortised cost and at fair value through OCI | - 43 | - 8 | 119 | 8 | 0 | 14 | રી સિ | 24 | 92 |
| on goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other | - 1 | - 24 | - 8 | 1 - |
0 | - 7 | - 1 | 0 | 32 l |
| Share in results of associated companies and joint ventures | 8 l |
16 | ব | 0 | 0 | 1 | 0 | 0 | 12 |
| RESULT BEFORE TAX | 1 486 | 581 | 514 | 171 | 89 | 86 | 165 | - 85 | 2 496 |
| Income tax expense | - 397 | - 98 | - 74 | - 25 | - 20 | - 9 | - 21 | 21 | = 548 |
| Net post-tax result from discontinued operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | O |
| RESULT AFTER TAX | 1 089 | 484 | 440 | 147 | 69 | 77 | 144 | - 64 | 1 949 |
| attributable to minority interests | 0 | 0 | O | 0 | 0 | 0 | O | 0 | 0 |
| attributable to equity holders of the parent | 1 089 | 484 | 440 | 147 | દિવ | 77 | 144 | - 64 | 1 948 |
| (in millions of EUR) | 9M 2019 | 9M 2018 | 3Q 2019 | 2Q 2019 | 3Q 2018 |
|---|---|---|---|---|---|
| Total | 3 436 | 3 378 | 1 174 | 1 132 | 1 136 |
| Interest income | 5 435 | 5 148 | 1 806 | 1 807 | 1 754 |
| Interest income on financial instruments calculated using the effective interest rate method | |||||
| Financial assets at AC | 4 147 | 3 908 | 1 404 | 1 383 | 1 341 |
| Financial assets at FVOCI | 249 | 291 | 84 | 78 | ત્ત્વે ઉત્પે |
| Hedging derivatives | 379 | 296 | 132 | 128 | 125 |
| Other assets not at fair value | 48 | 51 | 13 | 16 | 14 |
| Interest income on other financial instruments | |||||
| Financial assets MFVPL other than held for trading | 5 | 6 | 2 | 2 | |
| Financial assets held for trading | 606 | 595 | 171 | 201 | 179 |
| Of which economic hedges | 586 | 576 | 165 | 195 | 173 |
| Other financial assets at FVPL | 0 | 0 | 0 | 0 | O |
| Interest expense | -1 999 | -1 771 | - 632 | - 675 | - 618 |
| Interest expense on financial instruments calculated using the effective interest rate method | |||||
| Financial liabilities at AC | - 965 | - 817 | - 294 | - 332 | - 298 |
| Hedging derivatives | - 498 | - 429 | - 167 | - 167 | - 163 |
| Other | - 64 | - 97 | - 14 | - 25 | - 37 |
| Interest expense on other financial instruments | |||||
| Financial liabilities held for trading | - 436 | - 404 | - 145 | - 139 | - 112 |
| Of which economic hedges | - 408 | - 383 | - 134 | - 130 | - 106 |
| Other financial liabilities at FVPL | - 30 | 20 | - 10 | - 11 | - 7 |
| Net interest expense relating to defined benefit plans | 6 - |
- 4 | - 2 | 2 | - 1 |
Note: reclassification in 3Q 2018 and 9M 2018 of 37 million euros from interest income on financial assets at fair value through OCI to financial assets at amortised cost (related to the presentation of internal bond lending).
The result from financial instruments at fair value through profit or loss in 3Q 2019 is 43 million euros lower compared to 2Q 2019. The quarter-on-quarter decrease is due to:
Only partly compensated by :
• A positive change in MTM ALM derivatives
Compared to 3Q 2018, the result from financial instruments at fair value through profit or loss is 124 million euros lower in 3Q 2019, for a large part explained by:
Only partly compensated by:
• Higher net result on equity instruments (insurance)
The result from financial instruments at fair value through profit or loss in 9M 2019 is 178 million euros lower compared to 9M 2018, for a large part explained by:
• Negative MTM ALM derivatives in 9M 2019 compared to slightly positive MTM ALM derivatives in 9M 2018
Only partly compensated by:
• Higher net results on equity instruments (insurance)
| (in millions of EUR) | 9M 2019 | 9M 2018 | 3Q 2019 | 2Q 2019 | 3Q 2018 |
|---|---|---|---|---|---|
| Total | 1 289 | 1 312 | 444 | 435 | 424 |
| Fee and commission income | 1 833 | 1 853 | 629 | 616 | 606 |
| Fee and commission expense | - 543 | - 541 | - 185 | - 180 | - 182 |
| Breakdown by type | |||||
| Asset Management Services | 809 | 855 | 275 | 270 | 275 |
| Fee and commission income | 850 | 897 | 288 | 285 | 289 |
| Fee and commission expense | - 41 | 42 l |
- 13 | - 14 | 15 |
| Banking Services | 686 | 658 | 237 | 230 | 219 |
| Fee and commission income | 935 | 910 | 326 | 315 | 304 |
| Fee and commission expense | - 249 | - 252 | - 89 | - 85 | 85 |
| Distribution | - 207 | - 200 | 68 | 65 | 70 |
| Fee and commission income | 47 | 47 | 15 | 16 | 13 |
| Fee and commission expense | - 254 | - 247 | 83 | 82 | 83 |
| (in millions of EUR) | 9M 2019 9 9M 2018 | 3Q 2019 | 20 2019 | 3Q 2018 | |
|---|---|---|---|---|---|
| Total | 234 | 150 | 43 | 133 | 56 |
| of which gains or losses on | |||||
| Sale of financial assets measured at amortised cost | 11 | 17 | 7 | O | 5 |
| Repurchase of financial liabilities measured at amortised cost | 9 | O | 9 | O | O |
| of which other, including: | 215 | 133 | 27 | 133 | 51 |
| Income from (mainly operational) leasing activities, KBC Lease Group | 56 | 54 | 16 | 20 | 20 |
| Income from VAB Group | 33 | 44 | 11 | 11 | 14 |
| One-off effect revaluation of 55% share in CMSS | 82 | 0 | 82 | O | |
| Settlement of legacy legal cases | 9 | 15 | 3 | O | ട് |
| Provisioning for tracker mortgage review | - 22 | 0 | - 18 | - 4 | 0 |
Notes :
| (in millions of EUR) | Life | Non-life | Non- technical account |
TOTAL |
|---|---|---|---|---|
| 9M 2019 | ||||
| Earned premiums, insurance (before reinsurance) | 959 | 1 295 | 0 | 2 254 |
| Technical charges, insurance (before reinsurance) | - 966 | - 754 | 0 | - 1 720 |
| Net fee and commission income | - 21 | - 247 | 0 | - 268 |
| Ceded reinsurance result | - 2 | - 12 | 0 | - 14 |
| General administrative expenses | - 115 | - 189 | 2 - |
- 307 |
| Internal claims settlement expenses | - 7 | - 45 | 0 | - 52 |
| Indirect acquisition costs | - 24 | - 54 | 0 | - 78 |
| Administrative expenses | - 85 | - 90 | 0 | - 175 |
| Investment management fees | 0 | 0 | 2 ー |
- 2 |
| Technical result | - 144 | 92 | 2 | - 55 |
| Investment Income (*) | 374 | 68 | 18 | 460 |
| Technical-financial result | 230 | 160 | 16 | 405 |
| Share in results of associated companies and joint ventures | 3 | 3 | ||
| RESULT BEFORE TAX | 230 | 160 | 19 | 409 |
| Income tax expense | - 89 | |||
| RESULT AFTER TAX | 320 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 320 | |||
| 9M 2018 | ||||
| Earned premiums, insurance (before reinsurance) | 945 | 1 187 | 0 | 2 132 |
| Technical charges, insurance (before reinsurance) | - | - 612 | 0 | - 1 571 |
| Net fee and commission income | - 18 | - 231 | 0 | - 249 |
| Ceded reinsurance result | - 1 | - 28 | 0 | - 29 |
| General administrative expenses | - 116 | - 190 | 2 - |
- 308 |
| Internal claims settlement expenses | - 7 | - 44 | 0 | 51 |
| Indirect acquisition costs | - 25 | - 56 | 0 | 81 l |
| Administrative expenses | - 84 | - 90 | 0 | - 174 |
| Investment management fees | 0 | O | - 2 | - 2 |
| Technical result | - 148 | 127 | 2 l |
- 24 |
| Investment Income | 397 | ૯૩ | 39 | 498 |
| Technical-financial result | 249 | 189 | 37 | 475 |
| Share in results of associated companies and joint ventures | 3 | ਤ | ||
| RESULT BEFORE TAX | 249 | 189 | 40 | 478 |
| Income tax expense | - | - 111 | ||
| RESULT AFTER TAX | 366 | |||
| attributable to minority interest | 0 | |||
| attributable to equity holders of the parent | 366 |
(*) 9M 2019 consists of (in millions of EUR): Net interest income (347), Net Dividend income (40), Net result from financial instruments at fair value through profit and loss (75), Net realized result from debt instruments at fair value through OCI (1), Net other income (-2) and Impairment (-1). The non-technical account includes also results of non-insurance companies such as VAB group and ADD.
Note: Figures for premiums exclude the investment contracts without DPF (Discretionary Participation Features), which roughly coincide with the unit-linked products. Figures are before elimination of transactions between the bank and insurance entities of the group (more information in the 2018 annual accounts).
In 9M 2019 the technical result non-life was negatively impacted by:
The operating expenses for 3Q 2019 include 28 million euros related to bank (and insurance) levies (30 million euros in 2Q 2019; 26 million euros in 3Q 2018, 440 million euros in 9M 2019 and 421 million euros in 9M 2018). Application of IFRIC 21 (Levies) has as a consequence that certain levies are taken upfront in expense of the first quarter of the year.
| (in millions of EUR) | 9M 2019 | 9M 2018 | 3Q 2019 | 20 2019 | 3Q 2018 |
|---|---|---|---|---|---|
| Total | - 134 | 60 | - 26 | - 40 | 2 |
| lmpairment on financial assets at AC and at FVOCI | - 128 | 92 | 25 I |
- 36 | 8 |
| Of which impairment on financial assets at AC | - 129 | 90 | - 26 | - 35 | 8 |
| By product | |||||
| Loans and advances | - 114 | 82 | 19 I |
- 33 | 14 |
| Debt securities | 0 | 0 | 0 | 1 | |
| Off-balance-sheet commitments and financial guarantees | - 14 | 6 | 7 - |
3 l |
7 |
| By type | |||||
| Stage 1 (12-month ECL) | 25 | 19 | 8 | 15 । |
9 |
| Stage 2 (lifetime ECL) | 11 | 33 | 14 | 11 l |
15 |
| Stage 3 (non-performing; lifetime ECL) | - 120 | 87 | 32 | 18 । |
43 |
| Purchased or originated credit impaired assets | 5 | 11 - |
0 | 9 | 12 |
| Of which impairment on financial assets at FVOCI | 1 | 3 | 1 | 0 | 1 |
| Debt securities | 1 | 3 | 1 | 0 | 1 |
| Stage 1 (12-month ECL) | 0 | 2 | 1 | 0 | O |
| Stage 2 (lifetime ECL) | - | O | 1 | 0 | O |
| Stage 3 (non-performing; lifetime ECL) | 0 | O | 0 | 0 | O |
| Impairment on goodwill | 0 | 0 | 0 | 0 | 0 |
| Impairment on other | 6 I |
32 l |
1 1 |
ব l |
6 l |
| Intangible fixed assets (other than goodwill) | 3 - |
0 | 0 | 3 l |
0 |
| Property, plant and equipment (including investment property) | 1 - |
32 | O | 1 - |
ട l |
| Associated companies and joint ventures | 0 | 0 | O | 0 | O |
| Other | 2 - |
0 | 1 - |
0 | 1 |
The stage 3 impairments in 9M 2019 are attributable mainly to loan loss impairments in Belgium due to a number of corporate files.
One-off gain in income tax in 2Q 2019: a positive impact of 34m in income tax is linked to the new hedging policy of FX participations.
As a result of this new hedging policy, a substantial part of the existing hedges have been terminated. While the FX result on the termination of these hedges remains in OCI, the income tax impact is included in the income statement.
| (in millions of EUR) | Measured at amortised cost (AC) |
Measured at fair value through OCI (FVOCI) |
Mandatorily measured at FVPL (other than held for trading) (MFVPL excl. HFT) |
Held for trading (HFT) |
Designated at fair value (FVO) |
Hedging derivatives |
Total | Total excl. CMSS |
|---|---|---|---|---|---|---|---|---|
| FINANCIAL ASSETS, 30-09-2019 | ||||||||
| Loans and advances to credit institutions and investment firms (excl. reverse repos) |
5 811 | 0 | 0 | 0 | 0 | 0 | 5 811 | 5 811 |
| Loans and advances to customers (excl. reverse repos) | 154 696 | 0 | 167 | 0 | 0 | 0 | 154 863 | 150 321 |
| Trade receivables | 1 906 | 0 | 0 | 0 | 0 | 0 | 1 906 | 1 906 |
| Consumer credit | 5 400 | 0 | 82 | 0 | 0 | 0 | 5 482 | 4 519 |
| Mortgage loans | 66 381 | 0 | 74 | 0 | 0 | 0 | 66 456 | 62 898 |
| Term loans | es 8ea | 0 | 11 | 0 | 0 | 0 | 68 880 | ୧୫ ୫୬୪ |
| Finance lease | 5 829 | 0 | 0 | 0 | 0 | 0 | 5 829 | 5 829 |
| Current account advances | 5 491 | 0 | 0 | 0 | 0 | 0 | 5 491 | 5 491 |
| Other | 819 | 0 | 0 | 0 | 0 | 0 | 819 | 818 |
| Reverse repos | 29 959 | 0 | 0 | 113 | 0 | 0 | 30 072 | 29 502 |
| with credit institutions and investment firms | 28 496 | 0 | 0 | 113 | 0 | 0 | 28 608 | 28 039 |
| with customers | 1 464 | 0 | 0 | 0 | 0 | 0 | 1 464 | 1 464 |
| Equity instruments | 0 | 260 | 1 373 | 754 | 0 | 0 | 2 387 | 2 387 |
| Investment contracts (insurance) | 0 | 0 | 14 394 | O | 0 | 0 | 14 394 | 14 394 |
| Debt securities issued by | 42 078 | 19 096 | ୧୧ | 1 495 | 0 | 0 | 62 735 | 62 474 |
| Public bodies | 36 408 | 12 415 | 0 | 1 377 | 0 | 0 | 50 200 | 49 939 |
| Credit institutions and investment firms | 3 475 | 2 839 | 0 | 23 | 0 | 0 | 6 338 | 6 338 |
| Corporates | 2 194 | 3 842 | ୧୧ | વેરૂ | 0 | 0 | 6 197 | 6 197 |
| Derivatives | O | 0 | 0 | 6 551 | 0 | 184 | 6 734 | 6 734 |
| Other | 546 | 0 | 0 | 1 | 0 | 0 | 547 | 547 |
| Total | 233 090 | 19 356 | 16 000 | 8 915 | 0 | 184 | 277 544 | 272 171 |
| FINANCIAL ASSETS, 31-12-2018 Loans and advances to credit institutions and investment firms |
0 | 0 | 0 | |||||
| (excl. reverse repos) | 5 069 | 0 | 0 | 5 070 | ||||
| Loans and advances to customers (excl. reverse repos) | 146 954 | 0 | 85 | 0 | 13 | 0 | 147 052 | |
| Trade receivables | 4 197 | 0 | 0 | 0 | 0 | 0 | 4 197 | |
| Consumer credit | 4 520 | 0 | 0 | 0 | 0 | 0 | 4 520 | |
| Mortgage loans | 60 766 | 0 | 71 | 0 | 0 | 0 | 60 837 | |
| Term loans | 65 717 | 0 | 14 | 0 | 13 | 0 | 65 744 | |
| Finance lease | 5 618 | 0 | 0 | 0 | 0 | 0 | 5 618 | |
| Current account advances | 5 527 | 0 | 0 | 0 | 0 | 0 | 5 527 | |
| Other | 609 | 0 | 0 | 0 | 0 | 0 | 609 | |
| Reverse repos | 21 133 | 0 | 0 | 0 | 0 | 0 | 21 134 | |
| with credit institutions and investment firms | 20 976 | 0 | 0 | 0 | 0 | 0 | 20 977 | |
| with customers | 157 | 0 | 0 | 0 | 0 | 0 | 157 | |
| Equity instruments | 0 | 258 | 1 249 | 763 | O | 0 | 2 271 | |
| Investment contracts (insurance) | 0 | 0 | 13 837 | 0 | O | 0 | 13 837 | |
| Debt securities issued by | 41 649 | 18 020 | 54 | 714 | 0 | 0 | 60 437 | |
| Public bodies | 35 710 | 12 025 | 0 | 557 | 0 | 0 | 48 292 | |
| Credit institutions and investment firms | 3 032 | 2 579 | 0 | 76 | 0 | 0 | 5 687 | |
| Corporates | 2 907 | 3 417 | 54 | 81 | 0 | 0 | 6 458 | |
| Derivatives | O | 0 | O | 4 942 | 0 | 183 | 5 124 | |
| Other | 1 986 | 0 | 0 | 6 | 0 | 0 | 1 992 | |
| Total | 216 792 | 18 279 | 15 224 | 6 426 | 13 | 183 | 256 916 | |
| (in millions of EUR) | Measured at amortised cost (AC) |
Held for trading (HFT) |
Designated at fair value (FVO) |
Hedging derivatives |
Total | Total excl. CMSS |
|---|---|---|---|---|---|---|
| FINANCIAL LIABILITIES, 30-09-2019 | ||||||
| Deposits from credit institutions and investment firms (excl. repos) |
20 169 | 0 | 0 | 20 169 | 20 169 | |
| Deposits from customers and debt securities (excl. repos) | 202 471 | 290 | 2 509 | 205 270 | 199 969 | |
| Demand deposits | 84 297 | 0 | 0 | 84 297 | 84 297 | |
| Time deposits | 15 745 | 110 | 235 | 16 091 | 16 091 | |
| Savings accounts | 68 052 | 0 | 0 | 68 052 | 62 752 | |
| Special deposits | 2 516 | 0 | 0 | 2 516 | 2 516 | |
| Other deposits | 644 | 0 | 0 | 644 | 643 | |
| Certificates of deposit | 13 017 | 0 | 7 | 13 025 | 13 025 | |
| Savings certificates | 1 151 | 0 | 0 | 1 151 | 1 151 | |
| Non-convertible bonds | 13 938 | 180 | 2 061 | 16 179 | 16 179 | |
| Non-convertible subordinated liabilities | 3 111 | 0 | 205 | 3 316 | 3 316 | |
| Repos | 2 976 | 32 | 0 | 3 007 | 3 007 | |
| with credit institutions and investment firms | 2 031 | 12 | 0 | 2 043 | 2 043 | |
| with customers | 945 | 20 | 0 | 964 | 964 | |
| Liabilities under investment contracts | 0 | - | 13 456 | 13 456 | 13 456 | |
| Derivatives | - | 5 684 | 0 | 1 371 | 7 055 | 7 055 |
| Short positions | 1 128 | 0 | 1 128 | 1 128 | ||
| In equity instruments | 23 | 0 | 23 | 23 | ||
| In debt securities | 1 105 | 0 | 1 105 | 1 105 | ||
| Other | 2 634 | 0 | 0 | 2 634 | 2 604 | |
| Total | 228 250 | 7 134 | 15 965 | 1 371 | 252 719 | 247 388 |
| FINANCIAL LIABILITIES, 31-12-2018 Deposits from credit institutions and investment firms (excl. repos) |
23 684 | 0 | 0 | 23 684 | ||
| Deposits trom customers and debt securities (excl. repos) | 192 004 | 226 | 2 061 | 194 291 | ||
| Demand deposits | 79 893 | 0 | 0 | 79 893 | ||
| Time deposits | 16 499 | 49 | 296 | 16 844 | ||
| Savings accounts | 60 067 | 0 | 0 | 60 067 | ||
| Special deposits | 2 629 | 0 | 0 | 2 629 | ||
| Other deposits | 211 | 0 | 0 | 211 | ||
| Certificates of deposit | 15 575 | 0 | 8 | 15 283 | ||
| Savings certificates | 1 700 | 0 | 0 | 1 700 | ||
| Non-convertible bonds | 13 029 | 176 | 1 572 | 14 777 | ||
| Non-convertible subordinated liabilities | 2 402 | 0 | 186 | 2 588 | ||
| Repos | 1 001 | 0 | 0 | 1 001 | ||
| with credit institutions and investment firms | 932 | 0 | 0 | 932 | ||
| with customers | દિવે | 0 | 0 | 69 | ||
| Liabilities under investment contracts | 0 | - | 12 949 | 12 949 | ||
| Derivatives | ー | 4 673 | 0 | 1 111 | 5 784 | |
| Short positions | - | 935 | 0 | 935 | ||
| In equity instruments | 16 | 0 | 16 | |||
| In debt securities | 919 | 0 | 919 | |||
| Other | 3 982 | 0 | 0 | 3 983 | ||
| Total | 220 671 | 5 834 | 15 010 | 1 111 | 242 626 |
On June 24, KBC Bank Ireland closed the transaction announced on April 12 to sell its legacy performing corporate loan portfolio of roughly 260 million euros to Bank of Ireland.
We have dealt with the impact of the acquisition of the remaining shares of ČMSS in the pro forma 'Total excluding ČMSS' column, which helps provide a clear view of changes in financial assets and liabilities (excluding the acquisition of this company). For more information, please refer to Note 6.6.
In the course of 2Q 2019, the accounting treatment of recourse factoring was reassessed in accordance with IFRS and a change has been made as of 30 June 2019 implying a reduction of 834 million euros in trade receivables and time deposits and a reclassification of funded recourse contracts from trade receivables to term loans amounting to 1 683 million euros.
| 30-09-2019 | 31-12-2018 | |||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | Carrying value before impairment |
Impairment | after impairment |
Carrying value Carrying value before impairment |
Impairment | Carrying value after impairment |
| FINANCIAL ASSETS AT AMORTISED COST | ||||||
| Loans and advances | 193 382 | - 2 916 | 190 466 | 176 680 | - 3 523 | 173 157 |
| Stage 1 (12-month ECL) | 170 123 | - 134 | 169 988 | 153 081 | - 113 | 152 969 |
| Stage 2 (lifetime ECL) | 17 571 | - 292 | 17 279 | 16 983 | - 305 | 16 678 |
| Stage 3 (lifetime ECL) (*) | 5 526 | - 2 460 | 3 066 | 6 461 | - 3 062 | 3 399 |
| Purchased or originated credit impaired assets (POCI) |
163 | 31 l |
132 | 154 | - 42 | 112 |
| Debt Securities | 42 090 | - 12 | 42 078 | 41 660 | - 11 | 41 649 |
| Stage 1 (12-month ECL) | 42 012 | - 4 | 42 008 | 41 409 | - 5 | 41 405 |
| Stage 2 (lifetime ECL) | 71 | 2 - |
69 | 244 | 1 ー |
243 |
| Stage 3 (lifetime ECL) | 7 | 6 - |
1 | 7 | 6 - |
2 |
| Purchased or originated credit impaired assets (POCI) |
0 | 0 | 0 | 0 | 0 | 0 |
| FINANCIAL ASSETS AT FAIR VALUE THROUGH OCI | ||||||
| Debt Securities | 19 101 | - 5 | 19 096 | 18 026 | - 6 | 18 020 |
| Stage 1 (12-month ECL) | 19 044 | - 4 | 19 040 | 17 585 | 4 - |
17 581 |
| Stage 2 (lifetime ECL) | 57 | 0 | 56 | 441 | 2 - |
439 |
| Stage 3 (lifetime ECL) | 0 | 0 | 0 | 0 | 0 | O |
| Purchased or originated credit impaired assets (POCI) |
0 | 0 | 0 | 0 | 0 | 0 |
(*) A large part of the drop of impaired financial assets is related to the accounting write-off of certain fully provisioned legacy loans (0.8 billion euros in 9M 2019) mainly in Ireland.
For more details on how KBC defines and determines (i) fair value and the fair value hierarchy and (ii) level 3 valuations reference is made to notes 4.4 up to and including 4.7 of the annual accounts 2018.
| (in millions of EUR) | 30-09-2019 | 31-12-2018 | ||||||
|---|---|---|---|---|---|---|---|---|
| Fair value hierarchy | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total |
| FINANCIAL ASSETS AT FAIR VALUE | ||||||||
| Mandatorily measured at fair value through profit or loss (other than held for trading) |
15 263 | 467 | 271 | 16 000 | 14 645 | 423 | 156 | 15 224 |
| Held for trading | 1 837 | 5 787 | 290 | 8 915 | 1 018 | 4 412 | 996 | 6 426 |
| Designated upon initial recognition at fair value through profit or loss (FVO) |
0 | 0 | 0 | 0 | 0 | 13 | 0 | 13 |
| At fair value through OCI | 15 302 | 3 562 | 492 | 19 356 | 13 773 | 4 066 | 441 | 18 280 |
| Hedging derivatives | 0 | 184 | 0 | 184 | 0 | 183 | 0 | 183 |
| Total | 32 402 | 9 999 | 2 053 | 44 454 | 29 436 | 9 096 | 1 593 | 40 125 |
| FINANCIAL LIABILITIES AT FAIR VALUE | ||||||||
| Held for trading | 1 129 | 3 820 | 2 186 | 7 134 | 831 | 3 457 | 1 545 | 5 834 |
| Designated at fair value | 13 419 | 809 | 1 736 | 15 965 | 12 931 | 856 | 1 223 | 15 010 |
| Hedging derivatives | 0 | 1 371 | 0 | 371 | 0 | 1 111 | 0 | 1 111 |
| Total | 14 547 | 6 000 | 3 922 | 24 470 | 13 763 | 5 424 | 2 768 | 21 955 |
During the first 9 months of 2019, KBC transferred about 23 million euros' worth of financial assets and liabilities out of level 1 and into level 2. It also reclassified approximately 1 107 million euros' worth of financial assets and liabilities from level 2 to level 1. Most of these reclassifications were carried out due to an optimization in the level classification methodology.
During the first 9 months of 2019 significant movements in financial assets and liabilities classified in level 3 of the fair value hierarchy included the following:
• Financial assets mandatorily measured at fair value through profit and loss (other than held for trading): the fair value of loans and advances increased by 82 million euros, due primarily to new transactions, partly offset by instruments that had reached maturity. The fair value of equity instruments increased by 31 million euros, mainly as a consequence of new positions and by transfers into
level 3
| Quantities | 30-09-2019 | 31-12-2018 |
|---|---|---|
| Ordinary shares | 416 155 676 | 416 155 676 |
| of which ordinary shares that entitle the holder to a dividend payment | 416 155 676 | 416 155 676 |
| of which treasury shares | 42 285 | 50 284 |
| Additional information | ||
| Par value per share (in EUR) | 3.51 | 3.51 |
| Number of shares issued but not fully paid up | O | 0 |
The ordinary shares of KBC Group NV have no nominal value and are quoted on NYSE Euronext (Brussels).
The treasury shares almost fully relate to positions in shares of KBC Group to hedge outstanding equity derivatives.
On 17 April 2018, KBC Group NV placed 1 billion euros in Additional Tier-1 (AT1) instruments and on 26 February 2019 KBC Group NV placed 500 million euros Additional Tier-1 securities. Both transactions had no impact on the number of ordinary shares. Both AT1 Securities have been issued in view of a call of the existing 1.4 billion euros AT1 Securities issued in 2014. This call was done on 19 March 2019.
On 31 May 2019, ČSOB has acquired the remaining 45% stake in ČMSS from Bausparkasse Schwäbisch Hall (BSH) for a total consideration of 240 million euros. As a result, ČMSS is now fully consolidated (previously equity method).
The consolidated figures in this report incorporate the impact of the acquisition of the 45% stake in ČMSS:
| in millions of EUR | 30/09/2019 |
|---|---|
| Purchase or sale | Purchase |
| Percentage of shares bought (+) or sold (-) in the relevant year | ČMSS 45% |
| Total share percentage at the end of the relevant year | 100% |
| For business unit/segment | Czech Republic |
| Deal date (month and year) | May 2019 |
| Incorporation of the result of the company in the result of the group as of: | 01-06-2019 |
| Purchase price | 240 |
| Cashflow for acquiring or selling companies less cash and cash equivalents acquired | 439 |
| Recognised amounts of identifiable assets acquired | |
| and liabilities assumed - provisional fair value at 31 May 2019 | |
| Cash and cash balances with central banks | 729 |
| Financial assets | 4 959 |
| Held for trading | 4 855 |
| Fair value through OCI | 103 |
| Hedging derivatives | 0 |
| Fair value adjustments of hedged items in portfolio hedge of interest rate risk | 15 |
| Tax assets | 4 |
| Property and equipment | 20 |
| Goodwill and other intangible assets | 42 |
| Other assets | 7 |
| of which: cash and cash equivalents (included in the assets above) | 729 |
| Financial liabilities | 5 384 |
| Measured at amortised cost | 5 362 |
| Hedging derivatives | 22 |
| Tax liabilities | 10 |
| Provisions for risks and charges | 1 |
| Other liabilities | 33 |
| of which: cash and cash equivalents (included in the liabilities above) | 50 |
| (in millions of EUR) | 9M 2019 | 3Q 2019 | 2Q 2019 |
|---|---|---|---|
| Net interest income | 28 | 21 | 7 |
| Interest income | 55 | 41 | 14 |
| Interest expense | - 27 | - 20 | - 7 |
| Dividend income | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 0 | 0 | 0 |
| Net realised result from debt instruments at fair value through OCI | 0 | 0 | 0 |
| Net fee and commission income | 8 | 6 | 2 |
| Fee and commission income | 11 | 8 | 3 |
| Fee and commission expense | - 3 | - 2 | - 1 |
| Net other income | 82 | 0 | 82 |
| TOTAL INCOME | 119 | 27 | 91 |
| Operating expenses | - 16 | - 11 | - 5 |
| Staff expenses | - 7 | - 5 | - 2 |
| General administrative expenses | - 5 | - 3 | - 1 |
| Depreciation and amortisation of fixed assets | - 4 | - 3 | - 1 |
| Impairment | - 4 | - 2 | - 1 |
| on financial assets at AC and at FVOCI | - 4 | - 2 | - 1 |
| Share in results of associated companies and joint ventures | 9 | 0 | 4 |
| RESULT BEFORE TAX | 108 | 14 | 90 |
| Income tax expense | - 3 | - 3 | - 1 |
| RESULT AFTER TAX | 104 | 11 | 89 |
| attributable to equity holders of the parent | 104 | 11 | 89 |
In 2018 (both in 1Q 2018) :
Significant non-adjusting events between the balance sheet date (30 September 2019) and the publication of this report (14 November 2019): none.




The main source of credit risk is the loan portfolio of the bank. A snapshot of the banking portfolio is shown in the table below. It includes all payment credit, guarantee credit and standby credit granted by KBC to private persons, companies, governments and banks. Bonds held in the investment portfolio are included if they are corporate- or bank-issued, hence government bonds and trading book exposure are not included. Further on in this chapter, extensive information is provided on the credit portfolio of each business unit. Information specifically on sovereign bonds can be found under 'How do we manage our risks (in the annual accounts 2018)'.
| Credit risk: loan portfolio overview | ||
|---|---|---|
| Total loan portfolio (in billions of EUR) | 30-09-2019 | 31-12-2018 |
| Portfolio outstanding + undrawn 1 | 218 | 205 |
| Portfolio outstanding 1 | 177 | 165 |
| Total loan portfolio, by business unit (as a % of the portfolio of credit outstanding) | ||
| Belgium | 65% | 66% |
| Czech Republic | 18% | 16% |
| International Markets | 15% | 16% |
| Group Centre | 2% | 2% |
| Total | 100% | 100% |
| Total outstanding loan portfolio sector breakdown | ||
| Private persons Finance and insurance |
40.7% 8.7% |
39.9% 7.4% |
| Authorities | 3.2% | 3.5% |
| Corporates | 47.4% | 49.2% |
| services | 10.7% | 11.2% |
| distribution | 7.2% | 7.5% |
| real estate | 6.3% | 6.6% |
| building & construction | 3.9% | 4.1% |
| agriculture, farming, fishing | 2.6% | 2.7% |
| automotive food producers |
2.6% 1.7% |
2.5% 1.7% |
| electricity | 1.6% | 1.6% |
| metals | 1.4% | 1.6% |
| chemicals | 1.2% | 1.3% |
| machinery & heavy equipment | 1.0% | 1.1% |
| shipping | 0.9% | 0.9% |
| hotels, bars & restaurants | 0.7% | 0.7% |
| traders oil, gas & other fuels |
0.7% 0.6% |
0.9% 0.6% |
| electrotechnics | 0.6% | 0.6% |
| textile & apparel | 0.5% | 0.6% |
| other 2 | 3.1% | 3.0% |
| Total outstanding loan portfolio geographical breakdown | ||
| Home countries | 84.9% | 86.6% |
| Belgium | 52.2% | 55.0% |
| Czech Republic | 17.1% | 15.0% |
| Ireland Slovakia |
5.8% 4.8% |
6.5% 5.0% |
| Hungary | 3.0% | 3.2% |
| Bulgaria | 2.0% | 2.0% |
| Rest of Western Europe | 9.4% | 7.9% |
| France | 3.2% | 2.0% |
| Netherlands | 1.7% | 1.7% |
| Great Britain | 1.1% | 1.1% |
| Spain | 0.4% | 0.5% |
| Luxemburg Germany |
1.1% 0.7% |
0.7% 0.7% |
| other | 1.3% | 1.3% |
| Rest of Central Europe | 0.4% | 0.5% |
| Russia | 0.1% | 0.1% |
| other | 0.3% | 0.4% |
| North America | 1.5% | 1.4% |
| USA | 1.1% | 1.1% |
| Canada | 0.4% | 0.3% |
| Asia | 1.6% | 1.6% |
| China | 1.0% | 0.9% |
| Hong Kong Singapore |
0.2% 0.1% |
0.2% 0.2% |
| other | 0.3% | 0.3% |
| Rest of the world | 2.3% | 1.9% |
| 30-09-2019 | 31-12-2018 | |
|---|---|---|
| Loan portfolio by IFRS-9 ECL stage (part of portfolio, as % of the portfolio of credit outstanding) | ||
| Stage 1 (credit risk has not increased significantly since initial recognition) | 85% | 84% |
| of which: PD 1 - 4 | 63% | 63% |
| of which: PD 5 - 9 including unrated | 23% | 21% |
| Stage 2 (credit risk has increased significantly since initial recognition – not credit impaired) incl. POCI 3 | 11% | 12% |
| of which: PD 1 - 4 | 3% | 4% |
| of which: PD 5 - 9 including unrated | 8% | 8% |
| Stage 3 (credit risk has increased significantly since initial recognition – credit impaired) incl. POCI 3 | 4% | 4% |
| of which: PD 10 impaired loans | 2% | 2% |
| of which: more than 90 days past due (PD 11+12) | 2% | 2% |
| Impaired loans (in millions of EUR or %) | ||
| Amount outstanding | 6 197 | 7 151 |
| of which: more than 90 days past due | 3 547 | 4 099 |
| Ratio of impaired loans, per business unit | ||
| Belgium | 2.3% | 2.6% |
| Czech Republic | 2.3% | 2.4% |
| International Markets | 9.1% | 12.2% |
| Group Centre | 12.5% | 12.0% |
| Total | 3.5% | 4.3% |
| of which: more than 90 days past due | 2.0% | 2.5% |
| Stage 3 loan loss impairments (in millions of EUR) and Cover ratio (%) | ||
| Stage 3 loan loss impairments | 2 601 | 3 203 |
| of which: more than 90 days past due | 2 141 | 2 695 |
| Cover ratio of impaired loans | ||
| Stage 3 loan loss impairments / impaired loans | 42% | 45% |
| of which: more than 90 days past due | 60% | 66% |
| Cover ratio of impaired loans, mortgage loans excluded | ||
| Stage 3 loan loss impairments / impaired loans, mortgage loans excluded | 51% | 49% |
| of which: more than 90 days past due | 72% | 74% |
| Credit cost, by business unit (%) | ||
| Belgium | 0.16% | 0.09% |
| Czech Republic | 0.05% | 0.03% |
| International Markets | 0.02% | -0.46% |
| Slovakia | 0.27% | 0.06% |
| Hungary | -0.07% | -0.18% |
| Bulgaria | 0.32% | -0.31% |
| Ireland | -0.24% | -0.96% |
| Group Centre | -0.76% | -0.83% |
| Total | 0.10% | -0.04% |
1Outstanding portfolio includes all on-balance sheet commitments and off-balance sheet guarantees but excludes off-balance sheet undrawn commitments; the amounts are measured in Gross Carrying Amounts;
2Other includes corporate sectors not exceeding 0.5% concentration and unidentified sectors
3Purchased or originated credit impaired assets
Impaired loans are loans for which full (re)payment of the contractual cash flows is deemed unlikely. This coincides with KBC's Probability-of-Default-classes 10, 11 and 12 (see annual accounts FY 2018 - section on credit risk for more information on PD classification). These impaired loans are equal to 'non-performing loans' under the definition used by EBA.
Since 1Q18 a switch has been made in the reported 'outstanding' figures from drawn principal to the new IFRS 9 definition of gross carrying amount (GCA), i.e. including reserved and accrued interests. The additional inclusion of reserved interests led, among others, to an increase in the reported amount of impaired loans. Furthermore, the transaction scope of the credit portfolio was extended and now additionally includes the following 4 elements: (1) bank exposure (money market placements, documentary credit, accounts), (2) debtor risk KBC Commercial Finance, (3) unauthorized overdrafts, and (4) reverse repo (excl. central bank exposure).
As of June 2019, ČMSS is fully consolidated on the balance sheet, while previously according to the equity method. In view of this, the loan portfolio of ČMSS is also included in 30-09-2019 loan portfolio overview and amounts to 5 billion euros. The total loan portfolio of business unit Czech Republic excluding ČMSS is 27 billion euros.
| 30-09-2019, in millions of EUR | Belgium 1 | Foreign branches | Total Business Unit Belgium | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 106 528 | 8 043 | 114 570 | ||||||
| Counterparty break down | % outst. | % outst. | % outst. | ||||||
| SME / corporate | 39 358 | 36,9% | 8 043 | 100,0% | 47 400 | 41,4% | |||
| retail | 67 170 | 63,1% | 0 | 0,0% | 67 170 | 58,6% | |||
| o/w private | 36 421 | 34,2% | 0 | 0,0% | 36 421 | 31,8% | |||
| o/w companies | 30 749 | 28,9% | 0 | 0,0% | 30 749 | 26,8% | |||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ||||
| total | 34 677 | 32,6% | 56% | 0 | 0,0% | - | 34 677 | 30,3% | |
| o/w FX mortgages | 0 | 0,0% | - | 0 | 0,0% | - | 0 | 0,0% | |
| o/w ind. LTV > 100% | 634 | 0,6% | - | 0 | 0,0% | - | 634 | 0,6% | |
| Probability of default (PD) | % outst. | % outst. | % outst. | ||||||
| low risk (PD 1-4; 0.00%-0.80%) | 81 648 | 76,6% | 4 666 | 58,0% | 86 314 | 75,3% | |||
| medium risk (PD 5-7; 0.80%-6.40%) | 18 898 | 17,7% | 2 990 | 37,2% | 21 888 | 19,1% | |||
| high risk (PD 8-9; 6.40%-100.00%) | 3 273 | 3,1% | 177 | 2,2% | 3 449 | 3,0% | |||
| impaired loans (PD 10 - 12) | 2 377 | 2,2% | 202 | 2,5% | 2 579 | 2,3% | |||
| unrated | 332 | 0,3% | 8 | 0,1% | 340 | 0,3% | |||
| Overall risk indicators | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | |||
| outstanding impaired loans | 2 377 | 957 | 40,3% | 202 | 134 | 66,4% | 2 579 | 1 091 | 42,3% |
| o/w PD 10 impaired loans | 1 197 | 218 | 18,2% | 97 | 49 | 50,0% | 1 295 | 267 | 20,6% |
| o/w more than 90 days past due (PD 11+12) | 1 180 | 739 | 62,7% | 104 | 85 | 81,8% | 1 284 | 824 | 64,2% |
| all impairments (stage 1+2+3) | 1 136 | 151 | 1 287 | ||||||
| o/w stage 1+2 impairments (incl. POCI) | 179 | 17 | 196 | ||||||
| o/w stage 3 impairments (incl. POCI) | 957 | 134 | 1 091 | ||||||
| 2018 Credit cost ratio (CCR) | 0,10% | -0,05% | 0,09% | ||||||
| YTD 2019 CCR | 0,14% | 0,44% | 0,16% |
1 Belgium = KBC Bank (all retail and corporate credit lending activities except for the foreign branches), CBC, KBC Lease Belgium, KBC Immolease, KBC Commercial Finance,
KBC Credit Investments (part of non-legacy portfolio assigned to BU Belgium)
| Total portfolio outstanding | 31 583 | ||||
|---|---|---|---|---|---|
| Counterparty break down | |||||
| SME / corporate | 8 672 | 27,5% | |||
| retail | 22 911 | 72,5% | |||
| o/w private | 18 004 | 57,0% | |||
| o/w companies | 4 907 | 15,5% | |||
| Mortgage loans | % outst. % outst. 15 719 49,8% 0 0,0% 279 0,9% % outst. 18 005 57,0% 11 556 36,6% 1 236 3,9% 737 2,3% 48 0,2% stage 3 imp. 737 355 293 63 444 291 470 116 355 |
||||
| total | 61% | ||||
| o/w FX mortgages | - | ||||
| o/w ind. LTV > 100% | - | ||||
| Probability of default (PD) | |||||
| low risk (PD 1-4; 0.00%-0.80%) | |||||
| medium risk (PD 5-7; 0.80%-6.40%) | |||||
| high risk (PD 8-9; 6.40%-100.00%) | |||||
| impaired loans (PD 10 - 12) | |||||
| unrated | |||||
| 1 Overall risk indicators |
% cover | ||||
| outstanding impaired loans | 48,1% | ||||
| o/w PD 10 impaired loans | 21,6% | ||||
| o/w more than 90 days past due (PD 11+12) | 65,5% | ||||
| all impairments (stage 1+2+3) | |||||
| o/w stage 1+2 impairments (incl. POCI) | |||||
| o/w stage 3 impairments (incl. POCI) | |||||
| 2018 Credit cost ratio (CCR) | 0,03% | ||||
| YTD 2019 CCR | 0,05% |
1 CCR at country level in local currency
| Loan portfolio Business Unit International Markets 30-09-2019, in millions of EUR |
Ireland | Slovakia | Hungary | Bulgaria | Total Int Markets | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total portfolio outstanding | 10 025 | 8 186 | 5 279 | 3 464 | 26 954 | ||||||||||
| Counterparty break down | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| SME / corporate | 63 | 0,6% | 3 066 | 37,5% | 3 195 | 60,5% | 1 121 | 32,4% | 7 444 | 27,6% | |||||
| retail | 9 962 | 99,4% | 5 120 | 62,5% | 2 084 | 39,5% | 2 343 | 67,6% | 19 509 | 72,4% | |||||
| o/w private | 9 947 | 99,2% | 4 169 | 50,9% | 1 919 | 36,3% | 1 324 | 38,2% | 17 358 | 64,4% | |||||
| o/w companies | 15 | 0,2% | 951 | 11,6% | 166 | 3,1% | 1 019 | 29,4% | 2 151 | 8,0% | |||||
| Mortgage loans | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ind. LTV | % outst. | ||||||
| total | 9 880 | 98,6% | 68% | 3 663 | 44,7% | 66% | 1 602 | 30,4% | 66% | 702 | 20,3% | 64% | 15 847 | 58,8% | |
| o/w FX mortgages | 0 | 0,0% | - | 0 | 0,0% | - | 6 | 0,1% | 102% | 91 | 2,6% | 62% | 97 | 0,4% | |
| o/w ind. LTV > 100% | 815 | 8,1% | - | 27 | 0,3% | - | 113 | 2,1% | - | 27 | 0,8% | - | 983 | 3,6% | |
| Probability of default (PD) | % outst. | % outst. | % outst. | % outst. | % outst. | ||||||||||
| low risk (PD 1-4; 0.00%-0.80%) | 918 | 9,2% | 5 045 | 61,6% | 2 551 | 48,3% | 954 | 27,6% | 9 469 | 35,1% | |||||
| medium risk (PD 5-7; 0.80%-6.40%) | 6 542 | 65,3% | 2 319 | 28,3% | 2 330 | 44,1% | 1 813 | 52,3% | 13 004 | 48,2% | |||||
| high risk (PD 8-9; 6.40%-100.00%) | 815 | 8,1% | 654 | 8,0% | 231 | 4,4% | 298 | 8,6% | 1 999 | 7,4% | |||||
| impaired loans (PD 10 - 12) | 1 739 | 17,4% | 146 | 1,8% | 166 | 3,1% | 398 | 11,5% | 2 450 | 9,1% | |||||
| unrated | 0 | 0,0% | 22 | 0,3% | 1 | 0,0% | 0 | 0,0% | 33 | 0,1% | |||||
| Overall risk indicators 1 | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | stage 3 imp. | % cover | |||||
| outstanding impaired loans | 1 739 | 418 | 24,0% | 146 | 101 | 69,2% | 166 | 89 | 53,5% | 398 | 178 | 44,7% | 2 450 | 786 | 32,1% |
| o/w PD 10 impaired loans | 864 | 76 | 8,7% | 30 | 17 | 57,1% | 46 | 16 | 34,5% | 67 | 9 | 13,2% | 1 008 | 118 | 11,7% |
| o/w more than 90 days past due (PD 11+12) | 875 | 342 | 39,1% | 116 | 84 | 72,4% | 119 | 73 | 60,9% | 331 | 169 | 51,1% | 1 441 | 668 | 46,4% |
| all impairments (stage 1+2+3) | 444 | 155 | 109 | 208 | 915 | ||||||||||
| o/w stage 1+2 impairments (incl. POCI) | 26 | 54 | 20 | 29 | 129 | ||||||||||
| o/w stage 3 impairments (incl. POCI) | 418 | 101 | 89 | 178 | 786 | ||||||||||
| 2018 Credit cost ratio (CCR) | -0,96% | 0,06% | -0,18% | -0,31% | -0,46% | ||||||||||
| YTD 2019 CCR | -0,24% | 0,27% | -0,07% | 0,32% | 0,02% |
1 CCR at country level in local currency
| Total portfolio outstanding | 3 446 | ||
|---|---|---|---|
| Counterparty break down | % outst. | ||
| SME / corporate | 3 446 | 100,0% | |
| retail | 0 | 0,0% | |
| o/w private | 0 | 0,0% | |
| o/w companies | 0 | 0,0% | |
| Mortgage loans | % outst. | ind. LTV | |
| total | 0 | 0,0% | - |
| o/w FX mortgages | 0 | 0,0% | - |
| o/w ind. LTV > 100% | 0 | 0,0% | - |
| Probability of default (PD) | % outst. | ||
| low risk (PD 1-4; 0.00%-0.80%) | 2 724 | 79,1% | |
| medium risk (PD 5-7; 0.80%-6.40%) | 206 | 6,0% | |
| high risk (PD 8-9; 6.40%-100.00%) | 84 | 2,4% | |
| impaired loans (PD 10 - 12) | 431 | 12,5% | |
| unrated | 0 | 0,0% | |
| Overall risk indicators | stage 3 imp. | % cover | |
| outstanding impaired loans | 431 | 370 | 85,7% |
| o/w PD 10 impaired loans | 54 | 12 | 22,5% |
| o/w more than 90 days past due (PD 11+12) | 377 | 358 | 94,8% |
| all impairments (stage 1+2+3) | 389 | ||
| o/w stage 1+2 impairments (incl. POCI) | 19 | ||
| o/w stage 3 impairments (incl. POCI) | 370 | ||
| 2018 Credit cost ratio (CCR) | -0,83% | ||
| YTD 2019 CCR | -0,76% |
1 Total Group Centre = KBC Credit Investments (part of non-legacy portfolio assigned to BU Group) and KBC Bank part Group (a.o. activities in wind-down: e.g. ex-Antwerp Diamond Bank)
KBC reports its solvency at group, banking and insurance level, calculating it on the basis of IFRS figures and the relevant guidelines issued by the competent regulator.
We report the solvency of the group, the bank and the insurance company based on IFRS data and according to the rules imposed by the regulator. For the KBC group, this implies that we calculate our solvency ratios based on CRR/CRD IV. This regulation entered gradually into force on 1 January 2014. The general rule under CRR/CRD IV for insurance participations is that an insurance participation is deducted from common equity at group level, unless the competent authority grants permission to apply a risk weighting instead (Danish compromise). KBC received such permission from the supervisory authority and hence reports its solvency on the basis of a 370% risk weighting being applied to the holdings of own fund instruments of the insurance company, after having deconsolidated KBC Insurance from the group figures.
In addition to the solvency ratios under CRD IV/CRR, KBC is considered a financial conglomerate since it covers both significant banking and insurance activities. Therefore KBC also has to disclose its solvency position as calculated in accordance with the Financial Conglomerate Directive (FICOD; 2002/87/EC. This implies that available capital is calculated on the basis of the consolidated position of the group and the eligible items recognised as such under the prevailing sectorial rules, which are CRR/CRD IV for the banking business and Solvency II for the insurance business. The capital requirement for the insurance business based on Solvency II is multiplied by 12.5 to obtain a risk weighted asset equivalent.
The Internal Rating Based (IRB) approach is since its implementation in 2008 the primary approach to calculate KBC's risk weighted assets. This is, based on a full application of all the CRD IV/CRR rules, used for approximately 92% of the weighted credit risks, of which approx. 88% according to Advanced and approx. 4% according to Foundation approach. The remaining weighted credit risks (ca. 8%) are calculated according to the Standardised approach.
The minimum CET1 requirement that KBC is to uphold is set at 10.7% (fully loaded, Danish Compromise) which includes the CRR/CRD IV minimum requirement (4.5%), the Pillar 2 Requirement (1.75%) and the buffers set by national competent authorities (2.50% Capital Conservation Buffer, 1.50% Systemic Buffer and 0.45% Countercycle Buffer). Furthermore ECB has set a Pillar 2 Guidance of 1.00%.
Following table groups the solvency on the level of KBC Group according to different methodologies and calculation methods, including the deduction method.
| Overview of KBC Group's capital ratios In millions of EUR |
||||
|---|---|---|---|---|
| 30/09/2019 | numerator (common equity) |
denominator (total weighted risk volume) |
ratio (%) | |
| CRDIV, Common Equity ratio | ||||
| Danish Compromise | Fully loaded | 14 992 | 97 368 | 15,4% |
| Deduction Method | Fully loaded | 14 027 | 91 994 | 15,2% |
| Financial Conglomerates Directive | Fully loaded | 15 736 | 110 960 | 14,2% |
| 30-09-2019 | 31-12-2018 | |
|---|---|---|
| In millions of EUR | Fully loaded | Fully loaded |
| Total regulatory capital (after profit appropriation) | 18 409 | 18 217 |
| Tier-1 capital | 16 492 | 16 150 |
| Common equity | 14 992 | 15 150 |
| Parent shareholders' equity (after deconsolidating KBC Insurance) | 15 839 | 16 992 |
| Intangible fixed assets (incl deferred tax impact) (-) | - 669 | - 584 |
| Goodwill on consolidation (incl deferred tax impact) (-) | - 753 | - 602 |
| Minority interests | 0 | 0 |
| Hedging reserve (cash flow hedges) (-) | 1 436 | 1 263 |
| Valuation diff. in fin. liabilities at fair value - own credit risk (-) | - 10 | - 14 |
| Value adjustment due to the requirements for prudent valuation (-) | - 78 | - 63 |
| Dividend payout (-) | 0 | - 1 040 |
| Renumeration of AT1 instruments (-) | - 14 | - 7 |
| Deduction re. financing provided to shareholders (-) | - 66 | - 91 |
| Deduction re. Irrevocable payment commitments (-) | - 45 | - 32 |
| IRB provision shortfall (-) | - 130 | - 100 |
| Deferred tax assets on losses carried forward (-) | - 518 | - 571 |
| Limit on deferred tax assets from timing differences relying on future profitability and significant | ||
| participations in financial sector entities (-) | 0 | 0 |
| Additional going concern capital | 1 500 | 1 000 |
| CRR compliant AT1 instruments (2) | 1 500 | 1 000 |
| Minority interests to be included in additional going concern capital | 0 | 0 |
| Tier 2 capital | 1 918 | 2 067 |
| IRB provision excess (+) | 111 | 204 |
| Subordinated liabilities (3) | 1 806 | 1 864 |
| Subordinated loans non-consolidated financial sector entities (-) | 0 | 0 |
| Minority interests to be included in tier 2 capital | 0 | 0 |
| Total weighted risk volume | 97 368 | 94 875 |
| Banking | 88 089 | 85 474 |
| Insurance | 9 133 | 9 133 |
| Holding activities | 162 | 302 |
| Elimination of intercompany transactions | - 17 | - 34 |
| Solvency ratios | ||
| Common equity ratio (1) | 15,40% | 15,97% |
| Tier-1 ratio | 16,94% | 17,02% |
| Total capital ratio | 18,91% | 19,20% |
(1) No IFRS interim profit has been recognised for 9M19. When including 9M19 net result taking into account 59% pay-out (dividend + AT1 coupon), in line with the payout ratio in FY2018, the CET1 ratio at KBC Group (Danish Compromise) amounted to 15.9% at the end of 9M19.
(2) On February 26, 2019 KBC Group NV placed 500 million euros in non-dilutive, Additional Tier-1 securities. This AT1 instrument is a 5-year non-call perpetual with a temporary write-down at 5.125% CET1 and an initial coupon of 4.75% per annum, payable semi-annual.
(3) We received the approval of the ECB to call a 750 million euros Tier-2 instrument the 25th of November 2019 and to redeem a 45 million pond sterling grandfathered Additional Tier- 1 instrument by the 19th of December 2019. Regarding both instruments, the capital value has already been excluded from the Tier-2 capital. The Tier-2 call is replaced by a new 750 million euros Tier-2 instrument issued the 27th of August 2019.
| Leverage ratio KBC Group (Basel III fully loaded) In millions of EUR |
30-09-2019 | 31-12-2018 |
|---|---|---|
| Tier-1 capital (Danish compromise) | 16 492 | 16 150 |
| Total exposures | 275 514 | 266 594 |
| Total Assets | 294 830 | 283 808 |
| Deconsolidation KBC Insurance | -33 278 | -31 375 |
| Adjustment for derivatives | -4 568 | -3 105 |
| Adjustment for regulatory corrections in determining Basel III Tier-1 capital | -2 259 | -2 043 |
| Adjustment for securities financing transaction exposures | 1 325 | 408 |
| Off-balance sheet exposures | 19 465 | 18 900 |
| Leverage ratio | 5,99% | 6,06% |
As is the case for the KBC group, the solvency of KBC Bank is calculated based on CRR/CRD IV. The solvency of KBC Insurance is calculated on the basis of Solvency II rules as they became effective on 1 January 2016. The tables below show the tier-1 and CAD ratios calculated under Basel III (CRD IV/CRR) for KBC Bank, as well as the solvency ratio of KBC Insurance under Solvency II.
| KBC Bank consolidated - CRDIV/CRR | 30-09-2019 | 31-12-2018 |
|---|---|---|
| (in millions of EUR) | Fully loaded | Fully loaded |
| Total regulatory capital, after profit appropriation | 15 652 | 15 749 |
| Tier-1 capital (1) | 13 704 | 13 625 |
| Of which common equity (2) | 12 204 | 12 618 |
| Tier-2 capital (3) | 1 948 | 2 124 |
| Total weighted risks | 88 089 | 85 474 |
| Credit risk | 73 843 | 71 224 |
| Market risk | 2 840 | 3 198 |
| Operational risk | 11 406 | 11 051 |
| Solvency ratios | ||
| Common equity ratio | 13,9% | 14,8% |
| Tier-1 ratio | 15,6% | 15,9% |
| CAD ratio | 17,8% | 18,4% |
(1) On February 26, 2019 KBC Group NV placed 500 million euros in non-dilutive, Additional Tier-1 securities. This AT1 instrument is a 5-year non-call perpetual with a temporary write-down at 5.125% CET1 and an initial coupon of 4.75% per annum, payable semi-annual
(2) no IFRS interim profit has been recognised for 9M19.
(3) We received the approval of the ECB to call a Tier-2-benchmark the 25th of November 2019 and to redeem a grandfathered Additional Tier- 1 instrument by the 19th of December 2019. Regarding both instruments, the capital value has already been excluded from the Tier-2 capital. The Tier-2 call is replaced by a new Tier-2 benchmark issue the 27th of August 2019.
| Solvency II, KBC Insurance consolidated | 30-09-2019 | 31-12-2018 |
|---|---|---|
| (in millions of EUR) | ||
| Own Funds | 3 393 | 3 590 |
| Tier 1 | 2 893 | 3 090 |
| IFRS Parent shareholders equity | 3 680 | 2 728 |
| Dividend payout | - 337 | - 132 |
| Deduction intangible assets and goodwill (after tax) | - 126 | - 124 |
| Valuation differences (after tax) | - 479 | 341 |
| Volatility adjustment | 186 | 313 |
| Other | - 33 | - 35 |
| Tier 2 | 500 | 500 |
| Subordinated liabilities | 500 | 500 |
| Solvency Capital Requirement (SCR) | 1 818 | 1 651 |
| Market risk | 1 501 | 1 379 |
| Non-life | 582 | 557 |
| Life | 656 | 666 |
| Health | 231 | 190 |
| Counterparty | 124 | 111 |
| Diversification | - 975 | - 922 |
| Other | - 301 | - 331 |
| Solvency II ratio | 187% | 217% |
Besides the ECB and NBB, which supervise KBC on a going concern basis, KBC is also subject to requirements set by the Single Resolution Board (SRB). The SRB is developing resolution plans for the major banks in the euro area. The resolution plan for KBC is based on a Single Point of Entry (SPE) approach at the level of KBC Group with 'bail-in' as the primary resolution tool. MREL measures the amount of own funds and eligible liabilities that can be credibly and feasibly bailed-in.
At the end of September 2019, the MREL ratio based on instruments issued by KBC Group NV ('HoldCo MREL') stands at 9.9% of TLOF. Based on the broader SRB definition including also eligible OpCo instruments, the MREL ratio amounts to 10.2% as % of TLOF. The latter is above the SRB requirement for KBC to achieve 9.76% as % of TLOF by 01-05-2019 using both HoldCo and eligible OpCo instruments.
Details on our segments or business units are available in the company presentation
| Business Unit Belgium | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2019 | 2Q 2019 | 1Q 2019 | FY 2018 | 4Q 2018 | 3Q 2018 |
| Breakdown P&L | ||||||
| Net interest income | 637 | 621 | 625 | 2 576 | 647 | 637 |
| Non-life insurance before reinsurance | 129 | 111 | 94 | 527 | 142 | 139 |
| Earned premiums Non-life | 284 | 275 | 270 | 1 070 | 275 | 271 |
| Technical charges Non-life | -156 | -165 | -175 | -543 | -133 | -133 |
| Life insurance before reinsurance | -25 | -24 | -25 | -110 | -29 | -32 |
| Earned premiums Life | 217 | 233 | 268 | 998 | 309 | 204 |
| Technical charges Life | -242 | -256 | -293 | -1 108 | -338 | -235 |
| Ceded reinsurance result | -5 | 4 | 8 | -26 | -11 | -3 |
| Dividend income | 14 | 38 | 11 | 74 | 12 | 11 |
| Net result from financial instruments at fair value through profit or loss | -9 | 43 | 54 | 101 | -40 | 53 |
| Net realised result from debt instr FV through OCI | 4 | 0 | 0 | 0 | 0 | 0 |
| Net fee and commission income | 297 | 293 | 286 | 1 182 | 273 | 289 |
| Net other income | 51 | 50 | 45 | 225 | 73 | 44 |
| TOTAL INCOME | 1 092 | 1 135 | 1 099 | 4 549 | 1 068 | 1 139 |
| Operating expenses | -552 | -575 | -807 | -2 484 | -541 | -559 |
| Impairment | -21 | -31 | -83 | -93 | -49 | -4 |
| On financial assets at amortised cost and at FV through OCI | -21 | -30 | -82 | -91 | -48 | -3 |
| On other | 0 | -1 | -1 | -2 | -1 | -1 |
| Share in results of associated companies and joint ventures | -2 | -2 | -1 | -8 | -1 | -3 |
| RESULT BEFORE TAX | 517 | 526 | 208 | 1 963 | 478 | 573 |
| Income tax expense | -149 | -138 | -32 | -513 | -117 | -164 |
| RESULT AFTER TAX | 368 | 388 | 176 | 1 450 | 361 | 409 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 368 | 388 | 176 | 1 450 | 361 | 409 |
| Banking | 287 | 289 | 102 | 1 071 | 279 | 325 |
| Insurance | 81 | 99 | 74 | 379 | 82 | 84 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 100 945 | 101 125 | 100 686 | 99 650 | 99 650 | 98 978 |
| of which Mortgage loans (end of period) | 35 832 | 35 674 | 35 234 | 35 049 | 35 049 | 34 775 |
| Customer deposits and debt certificates excl. repos (end of period) | 134 355 | 128 544 | 134 382 | 131 442 | 131 442 | 131 862 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 13 097 | 13 144 | 13 141 | 13 176 | 13 176 | 13 336 |
| Unit-Linked (end of period) | 13 281 | 13 201 | 13 156 | 12 774 | 12 774 | 13 272 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 49 985 | 48 959 | 49 403 | 48 120 | 48 120 | 47 207 |
| Required capital, insurance (end of period) | 1 572 | 1 508 | 1 506 | 1 421 | 1 421 | 1 567 |
| Allocated capital (end of period) | 6 920 | 6 747 | 6 792 | 6 522 | 6 522 | 6 571 |
| Return on allocated capital (ROAC) | 22% | 23% | 11% | 22% | 22% | 25% |
| Cost/income ratio, banking | 53% | 54% | 78% | 58% | 53% | 51% |
| Combined ratio, non-life insurance | 91% | 91% | 93% | 87% | 86% | 86% |
| Net interest margin, banking | 1,68% | 1,67% | 1,71% | 1,72% | 1,72% | 1,69% |
| Business Unit Czech Republic | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2019 | 2Q 2019 | 1Q 2019 | FY 2018 | 4Q 2018 | 3Q 2018 |
| Breakdown P&L | ||||||
| Net interest income | 329 | 308 | 302 | 1 043 | 291 | 263 |
| Non-life insurance before reinsurance | 29 | 27 | 29 | 103 | 26 | 27 |
| Earned premiums Non-life | 72 | 70 | 66 | 248 | 64 | 65 |
| Technical charges Non-life | -43 | -42 | -37 | -145 | -38 | -38 |
| Life insurance before reinsurance | 13 | 15 | 14 | 58 | 14 | 14 |
| Earned premiums Life | 53 | 61 | 56 | 260 | 79 | 63 |
| Technical charges Life | -40 | -46 | -42 | -202 | -64 | -49 |
| Ceded reinsurance result | 0 | -2 | -3 | -8 | -3 | 0 |
| Dividend income | 0 | 0 | 0 | 1 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | -56 | -34 | -3 | 72 | 4 | 20 |
| Net realised result from debt instr FV through OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Net fee and commission income | 70 | 67 | 58 | 257 | 64 | 62 |
| Net other income | 2 | 84 | 13 | 14 | 4 | 3 |
| TOTAL INCOME | 388 | 465 | 410 | 1 540 | 400 | 388 |
| Operating expenses | -187 | -179 | -204 | -729 | -187 | -180 |
| Impairment | -9 | -7 | 1 | -42 | -10 | -16 |
| On financial assets at amortised cost and at FV through OCI | -9 | -4 | 2 | -8 | 0 | -12 |
| On other | 0 | -3 | 0 | -34 | -10 | -4 |
| Share in results of associated companies and joint ventures | 0 | 4 | 4 | 19 | 3 | 4 |
| RESULT BEFORE TAX | 192 | 283 | 212 | 788 | 207 | 196 |
| Income tax expense | -33 | -35 | -35 | -134 | -37 | -29 |
| RESULT AFTER TAX | 159 | 248 | 177 | 654 | 170 | 168 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 159 | 248 | 177 | 654 | 170 | 168 |
| Banking | 147 | 237 | 164 | 619 | 164 | 157 |
| Insurance | 12 | 11 | 13 | 35 | 6 | 10 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 29 200 | 28 711 | 23 685 | 23 387 | 23 387 | 23 305 |
| of which Mortgage loans (end of period) | 15 267 | 15 267 | 11 375 | 11 317 | 11 317 | 11 128 |
| Customer deposits and debt certificates excl. repos (end of period) | 38 170 | 38 536 | 32 210 | 32 394 | 32 394 | 32 063 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 616 | 621 | 613 | 613 | 613 | 611 |
| Unit-Linked (end of period) | 700 | 698 | 689 | 660 | 660 | 641 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 14 916 | 14 670 | 14 334 | 14 457 | 14 457 | 15 023 |
| Required capital, insurance (end of period) | 121 | 124 | 125 | 115 | 115 | 129 |
| Allocated capital (end of period) | 1 717 | 1 694 | 1 659 | 1 647 | 1 647 | 1 721 |
| Return on allocated capital (ROAC) | 38% | 60% | 43% | 39% | 40% | 39% |
| Cost/income ratio, banking | 48% | 38% | 50% | 47% | 45% | 46% |
| Combined ratio, non-life insurance | 94% | 96% | 93% | 97% | 101% | 96% |
| Net interest margin, banking (*) | 2,93% | 3,18% | 3,25% | 3,07% | 3,25% | 3,04% |
(*) As of 3Q 2019, ČMSS is taken fully into account
| Business Unit International Markets | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2019 | 2Q 2019 | 1Q 2019 | FY 2018 | 4Q 2018 | 3Q 2018 |
| Breakdown P&L | ||||||
| Net interest income | 216 | 214 | 213 | 896 | 222 | 226 |
| Non-life insurance before reinsurance | 32 | 35 | 35 | 117 | 29 | 31 |
| Earned premiums Non-life | 80 | 78 | 77 | 254 | 68 | 66 |
| Technical charges Non-life | -48 | -43 | -42 | -137 | -39 | -35 |
| Life insurance before reinsurance | 7 | 10 | 9 | 34 | 12 | 7 |
| Earned premiums Life | 21 | 23 | 27 | 101 | 27 | 25 |
| Technical charges Life | -14 | -14 | -18 | -67 | -15 | -18 |
| Ceded reinsurance result | -2 | -3 | -2 | -11 | -2 | -2 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 5 | 10 | 10 | 74 | 8 | 24 |
| Net realised result from debt instr FV through OCI | 1 | 0 | 1 | 0 | 0 | -1 |
| Net fee and commission income | 77 | 77 | 68 | 284 | 69 | 74 |
| Net other income | -16 | -2 | 3 | 17 | -1 | 2 |
| TOTAL INCOME | 321 | 340 | 336 | 1 412 | 338 | 361 |
| Operating expenses | -212 | -212 | -260 | -909 | -233 | -214 |
| Impairment | -6 | -7 | 7 | 118 | 6 | 18 |
| On financial assets at amortised cost and at FV through OCI | -5 | -6 | 8 | 127 | 8 | 19 |
| On other | -1 | -1 | 0 | -9 | -2 | -2 |
| Share in results of associated companies and joint ventures | 1 | 1 | 1 | 5 | 1 | 1 |
| RESULT BEFORE TAX | 104 | 122 | 85 | 626 | 111 | 165 |
| Income tax expense | -19 | -18 | -15 | -93 | -19 | -24 |
| RESULT AFTER TAX | 85 | 104 | 70 | 533 | 93 | 141 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 85 | 104 | 70 | 533 | 93 | 141 |
| Banking | 75 | 91 | 56 | 496 | 86 | 130 |
| Insurance | 11 | 13 | 14 | 37 | 7 | 11 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 24 718 | 24 333 | 24 146 | 24 015 | 24 015 | 23 728 |
| of which Mortgage loans (end of period) | 15 357 | 15 178 | 14 955 | 14 471 | 14 471 | 15 052 |
| Customer deposits and debt certificates excl. repos (end of period) | 22 939 | 22 970 | 23 063 | 22 897 | 22 897 | 22 408 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 258 | 262 | 261 | 257 | 257 | 255 |
| Unit-Linked (end of period) | 414 | 420 | 417 | 403 | 403 | 407 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 21 068 | 21 019 | 21 004 | 20 536 | 20 536 | 19 893 |
| Required capital, insurance (end of period) | 123 | 117 | 114 | 108 | 108 | 101 |
| Allocated capital (end of period) | 2 377 | 2 366 | 2 361 | 2 285 | 2 285 | 2 210 |
| Return on allocated capital (ROAC) | 14% | 18% | 12% | 24% | 17% | 26% |
| Cost/income ratio, banking | 67% | 64% | 80% | 65% | 69% | 60% |
| Combined ratio, non-life insurance | 93% | 88% | 84% | 90% | 95% | 89% |
| Net interest margin, banking | 2,61% | 2,65% | 2,69% | 2,80% | 2,74% | 2,79% |
| Hungary | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2019 | 2Q 2019 | 1Q 2019 | FY 2018 | 4Q 2018 | 3Q 2018 |
| Breakdown P&L | ||||||
| Net interest income | 64 | 64 | 62 | 243 | 62 | 60 |
| Non-life insurance before reinsurance | 10 | 12 | 12 | 42 | 11 | 10 |
| Earned premiums Non-life | 36 | 35 | 37 | 109 | 28 | 28 |
| Technical charges Non-life | -26 | -24 | -26 | -67 | -17 | -17 |
| Life insurance before reinsurance | 2 | 2 | 2 | 10 | 4 | 2 |
| Earned premiums Life | 4 | 4 | 4 | 17 | 4 | 4 |
| Technical charges Life | -2 | -2 | -3 | -6 | 0 | -2 |
| Ceded reinsurance result | -1 | 0 | -1 | -3 | -1 | -1 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 6 | 8 | 10 | 60 | 11 | 16 |
| Net realised result from debt instr FV through OCI | 1 | 0 | 0 | -1 | 0 | -1 |
| Net fee and commission income | 55 | 55 | 48 | 197 | 50 | 50 |
| Net other income | 0 | 0 | 1 | 15 | 1 | 1 |
| TOTAL INCOME | 137 | 142 | 133 | 565 | 138 | 138 |
| Operating expenses | -83 | -81 | -102 | -345 | -83 | -80 |
| Impairment | -1 | 3 | 0 | 9 | 1 | 0 |
| On financial assets at amortised cost and at FV through OCI | -1 | 3 | 0 | 9 | 1 | 1 |
| On other | 0 | 0 | 0 | -1 | 0 | -1 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 53 | 64 | 31 | 228 | 57 | 59 |
| Income tax expense | -8 | -9 | -6 | -32 | -8 | -8 |
| RESULT AFTER TAX Attributable to minority interest |
45 0 |
55 0 |
25 0 |
196 0 |
49 0 |
51 0 |
| Attributable to equity holders of the parent | 45 | 55 | 25 | 196 | 49 | 51 |
| Banking | 41 | 50 | 21 | 182 | 45 | 48 |
| Insurance | 4 | 4 | 4 | 14 | 4 | 3 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 4 522 | 4 527 | 4 395 | 4 373 | 4 373 | 4 287 |
| of which Mortgage loans (end of period) | 1 558 | 1 602 | 1 581 | 1 260 | 1 260 | 1 531 |
| Customer deposits and debt certificates excl. repos (end of period) | 7 140 | 7 388 | 7 484 | 7 503 | 7 503 | 7 019 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 52 | 55 | 55 | 55 | 55 | 53 |
| Unit-Linked (end of period) | 280 | 285 | 284 | 277 | 277 | 278 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 6 480 | 6 320 | 6 826 | 6 693 | 6 693 | 6 219 |
| Required capital, insurance (end of period) | 47 | 43 | 43 | 41 | 41 | 39 |
| Allocated capital (end of period) | 740 | 719 | 773 | 751 | 751 | 699 |
| Return on allocated capital (ROAC) | 24% | 29% | 13% | 28% | 29% | 31% |
| Cost/income ratio, banking | 62% | 58% | 79% | 62% | 60% | 57% |
| Combined ratio, non-life insurance | 96% | 90% | 89% | 90% | 92% | 95% |
| Slovakia | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2019 | 2Q 2019 | 1Q 2019 | FY 2018 | 4Q 2018 | 3Q 2018 |
| Breakdown P&L | ||||||
| Net interest income | 51 | 50 | 52 | 211 | 53 | 54 |
| Non-life insurance before reinsurance | 7 | 7 | 7 | 25 | 7 | 6 |
| Earned premiums Non-life | 12 | 12 | 11 | 41 | 11 | 11 |
| Technical charges Non-life | -5 | -4 | -4 | -16 | -4 | -4 |
| Life insurance before reinsurance | 2 | 3 | 3 | 13 | 4 | 3 |
| Earned premiums Life | 10 | 10 | 11 | 53 | 13 | 13 |
| Technical charges Life | -7 | -7 | -8 | -40 | -9 | -10 |
| Ceded reinsurance result | 0 | -1 | 0 | -2 | -1 | -1 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | -5 | -2 | 0 | 6 | 0 | 3 |
| Net realised result from debt instr FV through OCI | 0 | 0 | 1 | 0 | 0 | 0 |
| Net fee and commission income | 16 | 16 | 15 | 59 | 15 | 16 |
| Net other income | 2 | 1 | 2 | 4 | -1 | 1 |
| TOTAL INCOME | 74 | 75 | 80 | 316 | 76 | 84 |
| Operating expenses | -52 | -51 | -55 | -205 | -54 | -50 |
| Impairment On financial assets at amortised cost and at FV through OCI |
-6 -6 |
-8 -8 |
-3 -3 |
-4 -4 |
-5 -5 |
1 1 |
| On other | 0 | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 16 | 15 | 23 | 107 | 18 | 35 |
| Income tax expense | -4 | -4 | -5 | -25 | -5 | -8 |
| RESULT AFTER TAX | 12 | 11 | 18 | 82 | 13 | 27 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 12 | 11 | 18 | 82 | 13 | 27 |
| Banking | 10 | 8 | 15 | 73 | 12 | 24 |
| Insurance | 2 | 3 | 3 | 9 | 2 | 3 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 7 471 | 7 316 | 7 177 | 7 107 | 7 107 | 6 979 |
| of which Mortgage loans (end of period) | 3 593 | 3 482 | 3 381 | 3 248 | 3 248 | 3 193 |
| Customer deposits and debt certificates excl. repos (end of period) | 6 438 | 6 236 | 6 270 | 6 348 | 6 348 | 6 333 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 114 | 115 | 114 | 114 | 114 | 115 |
| Unit-Linked (end of period) | 97 | 104 | 106 | 104 | 104 | 107 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 5 030 | 4 960 | 5 121 | 5 056 | 5 056 | 5 048 |
| Required capital, insurance (end of period) | 28 | 26 | 24 | 23 | 23 | 24 |
| Allocated capital (end of period) | 566 | 557 | 572 | 559 | 559 | 559 |
| Return on allocated capital (ROAC) | 8% | 8% | 13% | 15% | 10% | 19% |
| Cost/income ratio, banking | 71% | 71% | 70% | 65% | 70% | 60% |
| Combined ratio, non-life insurance | 84% | 81% | 82% | 87% | 92% | 87% |
| Bulgaria | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2019 | 2Q 2019 | 1Q 2019 | FY 2018 | 4Q 2018 | 3Q 2018 |
| Breakdown P&L | ||||||
| Net interest income | 36 | 35 | 35 | 151 | 37 | 38 |
| Non-life insurance before reinsurance | 15 | 16 | 16 | 50 | 11 | 14 |
| Earned premiums Non-life | 32 | 31 | 29 | 104 | 29 | 27 |
| Technical charges Non-life | -17 | -15 | -12 | -54 | -18 | -13 |
| Life insurance before reinsurance | 3 | 4 | 4 | 12 | 5 | 2 |
| Earned premiums Life | 8 | 9 | 11 | 32 | 11 | 8 |
| Technical charges Life | -5 | -5 | -7 | -20 | -6 | -6 |
| Ceded reinsurance result | -2 | -2 | -2 | -6 | -1 | -1 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 4 | 4 | 4 | 13 | 3 | 3 |
| Net realised result from debt instr FV through OCI | 0 | 0 | 0 | 1 | 0 | 0 |
| Net fee and commission income | 6 | 6 | 6 | 29 | 6 | 7 |
| Net other income | 1 | 0 | 0 | -1 | 0 | 0 |
| TOTAL INCOME | 63 | 63 | 63 | 248 | 62 | 64 |
| Operating expenses | -30 | -29 | -47 | -143 | -35 | -31 |
| Impairment | -6 | -1 | -2 | 1 | -6 | 1 |
| On financial assets at amortised cost and at FV through OCI | -6 | -1 | -2 | 10 | -4 | 2 |
| On other | 0 | 0 | 0 | -9 | -2 | -1 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 1 | 0 | 0 |
| RESULT BEFORE TAX | 26 | 33 | 15 | 107 | 21 | 34 |
| Income tax expense | -3 | -3 | -2 | -11 | -2 | -3 |
| RESULT AFTER TAX | 23 | 29 | 13 | 96 | 19 | 31 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 23 | 29 | 13 | 96 | 19 | 31 |
| Banking | 20 | 24 | 7 | 86 | 18 | 26 |
| Insurance | 3 | 5 | 6 | 10 | 0 | 4 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 3 064 | 2 927 | 2 826 | 2 806 | 2 806 | 2 813 |
| of which Mortgage loans (end of period) | 675 | 659 | 645 | 642 | 642 | 1 094 |
| Customer deposits and debt certificates excl. repos (end of period) | 4 216 | 4 291 | 4 286 | 4 116 | 4 116 | 3 981 |
| Technical provisions plus unit-linked, life insurance | ||||||
| Interest Guaranteed (end of period) | 91 | 92 | 91 | 87 | 87 | 87 |
| Unit-Linked (end of period) | 37 | 31 | 27 | 22 | 22 | 22 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 3 338 | 3 554 | 3 237 | 2 991 | 2 991 | 3 081 |
| Required capital, insurance (end of period) | 48 | 48 | 47 | 44 | 44 | 38 |
| Allocated capital (end of period) | 405 | 428 | 393 | 361 | 361 | 365 |
| Return on allocated capital (ROAC) | 24% | 30% | 14% | 27% | 21% | 34% |
| Cost/income ratio, banking | 47% | 46% | 81% | 57% | 52% | 48% |
| Combined ratio, non-life insurance | 91% | 89% | 82% | 91% | 99% | 82% |
| Ireland | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2019 | 2Q 2019 | 1Q 2019 | FY 2018 | 4Q 2018 | 3Q 2018 |
| Breakdown P&L | ||||||
| Net interest income | 66 | 65 | 65 | 291 | 69 | 74 |
| Non-life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Non-life | 0 | 0 | 0 | 0 | 0 | 0 |
| Technical charges Non-life | 0 | 0 | 0 | 0 | 0 | 0 |
| Life insurance before reinsurance | 0 | 0 | 0 | 0 | 0 | 0 |
| Earned premiums Life | 0 | 0 | 0 | 0 | 0 | 0 |
| Technical charges Life | 0 | 0 | 0 | 0 | 0 | 0 |
| Ceded reinsurance result | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend income | 0 | 0 | 0 | 0 | 0 | 0 |
| Net result from financial instruments at fair value through profit or loss | 0 | 0 | -3 | -5 | -6 | 1 |
| Net realised result from debt instr FV through OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Net fee and commission income | 0 | -1 | -1 | -1 | -1 | 0 |
| Net other income | -18 | -4 | 0 | -1 | -1 | 0 |
| TOTAL INCOME | 48 | 61 | 60 | 284 | 61 | 75 |
| Operating expenses | -47 | -51 | -56 | -216 | -62 | -53 |
| Impairment | 7 | 0 | 12 | 111 | 15 | 15 |
| On financial assets at amortised cost and at FV through OCI | 7 | 0 | 12 | 112 | 15 | 15 |
| On other | 0 | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | 8 | 10 | 16 | 180 | 15 | 36 |
| Income tax expense | -3 | -1 | -2 | -24 | -4 | -5 |
| RESULT AFTER TAX | 4 | 9 | 14 | 155 | 11 | 32 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 4 | 9 | 14 | 155 | 11 | 32 |
| Banking | 4 | 9 | 14 | 155 | 11 | 32 |
| Insurance | 0 | 0 | 0 | 0 | 0 | 0 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 9 661 | 9 562 | 9 748 | 9 729 | 9 729 | 9 649 |
| of which Mortgage loans (end of period) | 9 531 | 9 435 | 9 348 | 9 320 | 9 320 | 9 235 |
| Customer deposits and debt certificates excl. repos (end of period) | 5 145 | 5 056 | 5 022 | 4 930 | 4 930 | 5 074 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 6 216 | 6 182 | 5 817 | 5 793 | 5 793 | 5 539 |
| Allocated capital (end of period) | 665 | 661 | 622 | 614 | 614 | 587 |
| Return on allocated capital (ROAC) | 3% | 5% | 9% | 26% | 7% | 21% |
| Cost/income ratio, banking | 98% | 84% | 93% | 76% | 101% | 71% |
| Group centre - Breakdown net result | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2019 | 2Q 2019 | 1Q 2019 | FY 2018 | 4Q 2018 | 3Q 2018 |
| Operational costs of the Group activities | -14 | -14 | -18 | -77 | -28 | -18 |
| Capital and treasury management | -9 | -7 | -3 | 19 | 11 | 4 |
| Holding of participations | 1 | 21 | -11 | -10 | -9 | -4 |
| Results companies in rundown | 12 | 5 | 4 | 58 | 15 | 10 |
| Other | 9 | -1 | 34 | -57 | 8 | -10 |
| Total net result for the Group centre | 0 | 4 | 7 | -67 | -3 | -17 |
| Group Centre | ||||||
|---|---|---|---|---|---|---|
| (in millions of EUR) | 3Q 2019 | 2Q 2019 | 1Q 2019 | FY 2018 | 4Q 2018 | 3Q 2018 |
| Breakdown P&L | ||||||
| Net interest income | -8 | -11 | -11 | 29 | 6 | 10 |
| Non-life insurance before reinsurance | 2 | 2 | 3 | 12 | 2 | 1 |
| Earned premiums Non-life | 3 | 3 | 2 | 10 | 2 | 1 |
| Technical charges Non-life | -2 | -1 | 1 | 2 | 0 | 0 |
| Life insurance before reinsurance | 0 | 0 | 0 | -1 | -1 | 1 |
| Earned premiums Life | 0 | 0 | 0 | 0 | 0 | 0 |
| Technical charges Life | 0 | 0 | 0 | 0 | -1 | 0 |
| Ceded reinsurance result | -1 | 2 | -10 | 4 | 4 | -1 |
| Dividend income | 0 | 1 | 1 | 7 | 2 | 1 |
| Net result from financial instruments at fair value through profit or loss | 14 | -21 | 38 | -17 | 29 | -19 |
| Net realised result from debt instr FV through OCI | 0 | 0 | 0 | 9 | 0 | 1 |
| Net fee and commission income | 0 | -1 | -2 | -3 | 0 | -1 |
| Net other income | 5 | 2 | -2 | -30 | -1 | 8 |
| TOTAL INCOME | 12 | -27 | 17 | 11 | 42 | 0 |
| Operating expenses | -23 | -21 | -24 | -112 | -34 | -28 |
| Impairment | 10 | 5 | 6 | 35 | 10 | 4 |
| On financial assets at amortised cost and at FV through OCI | 10 | 5 | 6 | 35 | 10 | 4 |
| On other | 0 | 0 | 0 | 0 | 0 | 0 |
| Share in results of associated companies and joint ventures | 0 | 0 | 0 | 0 | 0 | 0 |
| RESULT BEFORE TAX | -1 | -43 | -2 | -67 | 18 | -24 |
| Income tax expense | 1 | 47 | 9 | 0 | -20 | 7 |
| RESULT AFTER TAX | 0 | 4 | 7 | -67 | -3 | -17 |
| Attributable to minority interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Attributable to equity holders of the parent | 0 | 4 | 7 | -67 | -3 | -17 |
| Of which banking | 5 | 0 | 12 | -8 | 10 | -8 |
| Of which holding | -1 | 3 | -1 | -67 | -10 | -12 |
| Of which insurance | -4 | 1 | -4 | 7 | -2 | 3 |
| Breakdown Loans and deposits | ||||||
| Total customer loans excluding reverse repo (end of period) | 0 | 0 | 0 | 0 | 0 | 0 |
| of which Mortgage loans (end of period) | 0 | 0 | 0 | 0 | 0 | 0 |
| Customer deposits and debt certificates excl. repos (end of period) | 9 806 | 9 089 | 8 332 | 7 558 | 7 558 | 7 723 |
| Performance Indicators | ||||||
| Risk-weighted assets, banking (end of period, Basel III fully loaded) | 2 266 | 2 607 | 2 652 | 2 629 | 2 629 | 2 725 |
| Risk-weighted assets, insurance (end of period, Basel III fully loaded) | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 | 9 133 |
| Required capital, insurance (end of period) | 2 | 5 | 6 | 7 | 7 | -25 |
| Allocated capital (end of period) | 245 | 284 | 290 | 286 | 286 | 264 |
Gives an idea of the amount of profit over a certain period that is attributable to one share (and, where applicable, including dilutive instruments).
| Calculation (in millions of EUR) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) | 'Consolidated income statement' | 1 787 | 2 570 | 1 948 |
| - | ||||
| Coupon on the additional tier-1 instruments included in equity (B) | 'Consolidated statement of changes in equity' | - 43 | - 76 | - 55 |
| / | ||||
| Average number of ordinary shares less treasury shares (in millions) in the period (C) |
Note 5.10 | 416,1 | 417,0 | 417,3 |
| or | ||||
| Average number of ordinary shares plus dilutive options less | 416,2 | 417,0 | 417,4 | |
| treasury shares in the period (D) | ||||
| Basic = (A-B) / (C) (in EUR) | 4,19 | 5,98 | 4,54 | |
| Diluted = (A-B) / (D) (in EUR) | 4,19 | 5,98 | 4,54 | |
| Combined ratio (non-life insurance) Gives an insight into the technical profitability (i.e. after eliminating investment returns, among other items) of the non-life insurance business, more particularly the extent to which insurance premiums adequately cover claim payments and expenses. The combined ratio takes ceded reinsurance into account. |
||||
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
| Technical insurance charges, including the internal cost of settling | Note 3.7.1 | 779 | 878 | 651 |
| claims (A) / |
||||
| Earned insurance premiums (B) + |
Note 3.7.1 | 1 260 | 1 553 | 1 151 |
| Operating expenses (C) | Note 3.7.1 | 398 | 505 | 383 |
| / Written insurance premiums (D) |
Note 3.7.1 | 1 334 | 1 597 | 1 230 |
| = (A/B)+(C/D) | 91,7% | 88,2% | 87,7% | |
| Common equity ratio A risk-weighted measure of the group's solvency, based on common equity tier-1 capital. |
||||
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
| 'Detailed calculation 'Danish compromise' table in the 'Solvency KBC Group' section.' | ||||
| Fully loaded | 15,4% | 16,0% | 16,0% | |
| No interim profit has been recognized for 9M19. When including 9M19 net result taking into account 59% pay-out (dividend + AT1 coupon), in line with the payout ratio in FY2018, the CET1 ratio at KBC Group (Danish Compromise) amounted to 15.9% at the end of 9M19. Cost/income ratio |
||||
| Gives an impression of the relative cost efficiency (costs relative to income) of the banking activities. | ||||
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
| Cost/income ratio | ||||
| Operating expenses of the banking activities (A) | 'Consolidated income statement': component of 'Operating expenses' |
2 895 | 3 714 | 2 857 |
| / | ||||
| Total income of the banking activities (B) | 'Consolidated income statement': component of 'Total income' |
4 813 | 6 459 | 4 865 |
| =(A) / (B) | 60,2% | 57,5% | 58,7% | |
| Where relevant, we also estimate exceptional and/or non-operating items when calculating the cost/income ratio. The adjustments include: MTM ALM derivatives (fully excluded), bank taxes (including contributions to European Single Resolution Fund) are included pro rata and hence spread over all quarters of the year instead of being recognised for the most part upfront (as required by IFRIC 21) and one-off items. The Cost/Income ratio adjusted for specific items is 59% in 9M 2019 (versus 57% in FY 2018 and 57% in 9M 2018). |
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Technical insurance charges, including the internal cost of settling claims (A) / |
Note 3.7.1 | 779 | 878 | 651 |
| Earned insurance premiums (B) | Note 3.7.1 | 1 260 | 1 553 | 1 151 |
| + Operating expenses (C) / |
Note 3.7.1 | 398 | 505 | 383 |
| Written insurance premiums (D) | Note 3.7.1 | 1 334 | 1 597 | 1 230 |
| = (A/B)+(C/D) | 91,7% | 88,2% | 87,7% |
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| 'Detailed calculation 'Danish compromise' table in the 'Solvency KBC Group' section.' | ||||
| Fully loaded | 15,4% | 16,0% | 16,0% | |
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Cost/income ratio | ||||
| Operating expenses of the banking activities (A) / |
'Consolidated income statement': component of 'Operating expenses' |
2 895 | 3 714 | 2 857 |
| Total income of the banking activities (B) | 'Consolidated income statement': component of 'Total income' |
4 813 | 6 459 | 4 865 |
| =(A) / (B) | 60,2% | 57,5% | 58,7% |
Indicates the proportion of impaired loans (see 'Impaired loans ratio' for definition) that are covered by impairment charges. Where appropriate, the numerator and denominator in the formula may be limited to impaired loans that are more than 90 days past due.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Specific impairment on loans (A) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
2 601 | 3 203 | 4 296 |
| / | ||||
| Outstanding impaired loans (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
6 197 | 7 151 | 9 103 |
| = (A) / (B) | 42,0% | 44,8% | 47,2% |
As of 1Q18 a switch has been made in the risk reporting figures from outstanding to the new definition of gross carrying amount, i.e. including reserved and accrued interests and moreover the transaction scope of the loan portfolio has been extended.
Gives an idea of loan impairment charges recognised in the income statement for a specific period, relative to the total loan portfolio (see 'Loan portfolio' for definition). In the longer term, this ratio can provide an indication of the credit quality of the portfolio.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Net changes in impairment for credit risks (A) / |
'Consolidated income statement': component of 'Impairment' |
129 | - 59 | - 90 |
| Average outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
170 689 | 163 393 | 164 391 |
| = (A) (annualised) / (B) | 0,10% | -0,04% | -0,07% |
Indicates the proportion of impaired loans in the loan portfolio (see 'Loan portfolio' for definition) and, therefore, gives an idea of the creditworthiness of the portfolio. Impaired loans are loans where it is unlikely that the full contractual principal and interest will be repaid/paid. These loans have a KBC default status of PD 10, PD 11 or PD 12 and correspond to the definition of 'nonperforming' used by the European Banking Authority.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Amount outstanding of impaired loans (A) / |
'Credit risk: loan portfolio overview' table in the 'Credit risk' section |
6 197 | 7 151 | 9 103 |
| Total outstanding loan portfolio (B) | 'Credit risk: loan portfolio overview in the 'Credit risk' section |
176 553 | 164 824 | 166 822 |
| = (A) / (B) | 3,5% | 4,3% | 5,5% |
As of 1Q18 a switch has been made in the risk reporting figures from outstanding to the new definition of gross carrying amount, i.e. including reserved and accrued interests. In addition, the transaction scope of the loan portfolio was extended and now additionally includes the following 4 elements: (1) bank exposure (money market placements, documentary credit, accounts), (2) debtor risk KBC Commercial Finance, (3) unauthorized overdrafts, and (4) reverse repo (excl. central bank exposure).
Gives an idea of the group's solvency, based on a simple non-risk-weighted ratio.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Regulatory available tier-1 capital (A) | Leverage ratio KBC Group (Basel III fully loaded' table in the 'Leverage KBC Group' section) |
16 492 | 16 150 | 17 418 |
| / | ||||
| Total exposure measures (total of non-risk-weighted on and off balance sheet items, with a number of adjustments) (B) |
Leverage ratio KBC Group (Basel III fully loaded' table in the 'Leverage KBC Group' section) |
275 514 | 266 594 | 286 388 |
| = (A) / (B) | 6,0% | 6,1% | 6,1% |
Gives an idea of the bank's liquidity position in the short term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-month period.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Stock of high-quality liquid assets (A) / |
Based on the European Commission's Delegated Act on LCR and the European Banking Authority's guidelines for LCR disclosure |
76 500 | 79 300 | 79 747 |
| Total net cash outflows over the next 30 calendar days (B) | 54 750 | 57 200 | 57 631 | |
| = (A) / (B) | 140% | 139% | 138% |
From year-end 2017 actuals, KBC discloses 12 months average LCR in accordance to EBA guidelines on LCR disclosure.
Gives an idea of the magnitude of (what are mainly pure, traditional) lending activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Loans and advances to customers (A) | Note 4.1, component of 'Loans and advances to customers' |
154 863 | 147 052 | 146 011 |
| + | ||||
| Reverse repos (not with Central Banks) (B) | Note 4.1, component of 'Reverse repos with credit institutions and investment firms' |
4 008 | 538 | 1 363 |
| + | ||||
| Debt instruments issued by corporates and by credit institutions and investment firms (banking) (C) |
Note 4.1, component of 'Debt instruments issued by corporates and by credit institutions and investment firms' |
5 751 | 5 750 | 5 761 |
| + | ||||
| Other exposures to credit institutions (D) | 4 954 | 4 603 | 5 215 | |
| + | ||||
| Financial guarantees granted to clients (E) | Note 6.1, component of 'Financial guarantees given' | 8 076 | 8 302 | 8 352 |
| + | ||||
| Impairment on loans (F) | Note 4.2, component of 'Impairment' | 2 928 | 3 534 | 3 735 |
| + | ||||
| Insurance entities (G) | Note 4.1, component of 'Loans and advances to customers' |
- 2 308 | - 2 296 | - 2 214 |
| + | ||||
| Non-loan-related receivables (H) | - 715 | - 517 | - 930 | |
| + | ||||
| Other (I) | Component of Note 4.1 | - 1 005 | - 2 142 | - 473 |
| = (A)+(B)+(C)+(D)+(E)+(F)+(G)+(H)+(I) | 176 553 | 164 824 | 166 822 |
As of 1Q18 a switch has been made in the risk reporting figures from 'outstanding' to the new definition of 'gross carrying amount', i.e. including reserved and accrued interests. In addition, the transaction scope of the loan portfolio was extended and now additionally includes the following 4 elements: (1) bank exposure (money market placements, documentary credit, accounts), (2) debtor risk KBC Commercial Finance, (3) unauthorized overdrafts, and (4) reverse repo (excl. central bank exposure).
Gives an idea of the net interest income of the banking activities (one of the most important sources of revenue for the group) relative to the average total interest-bearing assets of the banking activities.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Net interest income of the banking activities (A) | 'Consolidated income statement': component of 'Net interest income' |
2 867 | 3 813 | 2 844 |
| / Average interest-bearing assets of the banking activities (B) |
'Consolidated balance sheet': component of 'Total assets' |
193 407 | 187 703 | 187 657 |
| = (A) (annualised x360/number of calendar days) / (B) | 1,95% | 2,00% | 2,00% |
From 1Q 2018 the definition of NIM has been updated, it concerns banking group NII excluding dealing room and the net positive impact of ALM FX swaps & repos.
Gives an idea of the bank's structural liquidity position in the long term, more specifically the extent to which the group is able to overcome liquidity difficulties over a one-year period.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Available amount of stable funding (A) | Basel III, the net stable funding ratio (Basel Committee on Banking Supervision publication, October 2014) |
173 000 | 165 650 | 164 300 |
| / | ||||
| Required amount of stable funding (B) | 128 600 | 122 150 | 122 500 | |
| = (A) / (B) | 134,5% | 135,6% | 134,1% |
Gives the carrying value of a KBC share, i.e. the value in euros represented by each share in the parent shareholders' equity of KBC.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Parent shareholders' equity (A) | 'Consolidated balance sheet' | 18 086 | 17 233 | 16 878 |
| / | ||||
| Number of ordinary shares less treasury shares (at period-end) (B) Note 5.10 | 416,1 | 416,1 | 415,8 | |
| = (A) / (B) (in EUR) | 43,46 | 41,42 | 40,59 |
Gives an idea of the relative profitability of a business unit, more specifically the ratio of the net result to the capital allocated to the business unit.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| BELGIUM BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) Note 2.2: Results by segment | 932 | 1 450 | 1 089 | |
| / | ||||
| The average amount of capital allocated to the business unit is | 6 757 | 6 496 | 6 490 | |
| based on the risk-weighted assets for the banking activities (under | ||||
| Basel III) and risk-weighted asset equivalents for the insurance | ||||
| activities (under Solvency II) (B) | ||||
| = (A) annualised / (B) | 18,4% | 22,3% | 22,4% | |
| CZECH REPUBLIC BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) Note 2.2: Results by segment | 584 | 654 | 484 | |
| / | ||||
| The average amount of capital allocated to the business unit is | 1 683 | 1 696 | 1 708 | |
| based on the risk-weighted assets for the banking activities (under | ||||
| Basel III) and risk-weighted asset equivalents for the insurance | ||||
| activities (under Solvency II) (B) | ||||
| = (A) annualised / (B) | 46,3% | 38,5% | 37,6% | |
| INTERNATIONAL MARKETS BUSINESS UNIT | ||||
| Result after tax (including minority interests) of the business unit (A) Note 2.2: Results by segment | 260 | 533 | 440 | |
| / | ||||
| The average amount of capital allocated to the business unit is | 2 352 | 2 204 | 2 184 | |
| based on the risk-weighted assets for the banking activities (under | ||||
| Basel III) and risk-weighted asset equivalents for the insurance | ||||
| activities (under Solvency II) (B) | ||||
| = (A) annualised / (B) | 14,7% | 24,2% | 26,9% |
Gives an idea of the relative profitability of the group, more specifically the ratio of the net result to equity.
| Calculation (in millions of EUR or %) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Result after tax, attributable to equity holders of the parent (A) (annualised) - |
'Consolidated income statement' | 1 787 | 2 570 | 1 948 |
| Coupon on the additional tier-1 instruments included in equity (B) (annualised) / |
'Consolidated statement of changes in equity' | - 44 | - 76 | - 55 |
| Average parent shareholders' equity, excluding the revaluation reserve for FVOCI instruments and for FVPL equity instruments – overlay approach (C) |
'Consolidated statement of changes in equity' | 16 477 | 15 935 | 15 665 |
| = (A-B) (annualised) / (C) | 14,1% | 15,6% | 16,1% | |
The return on equity in 9M 2019 including evenly spread of the bank tax throughout the year is 15%.
Gives the indication of the sales activities of life insurance products including unit-linked.
| Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|
| 'Consolidated income statement' | 959 | 1 359 | 944 |
| - | 0 | 0 | - 1 |
| 364 | |||
| 1 378 | 1 817 | 1 307 | |
| - | 419 | 457 |
Measures the solvency of the insurance business, calculated under Solvency II.
| Calculation | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|
| Detailed calculation under 'Solvency II, KBC Insurance consolidated' table in the Solvency banking and insurance activities | 187% | 217% | 216% |
| separately section |
Total assets under management (AuM) comprise third-party assets and KBC group assets managed by the group's various asset management companies (KBC Asset Management, ČSOB Asset Management, etc.), as well as assets under advisory management at KBC Bank. The assets, therefore, consist mainly of KBC investment funds and unit-linked insurance products, assets under discretionary and advisory management mandates of (mainly retail, private banking and institutional) clients, and certain group assets. The size and development of total AuM are major factors behind net fee and commission income (generating entry and management fees) and hence account for a large part of any change in this income line. In that respect, the AuM of a fund that is not sold directly to clients but is instead invested in by another fund or via a discretionary/advisory management portfolio, are also included in the total AuM figure, in view of the related work and any fee income linked to them.
| Calculation (in billions of EUR or quantity) | Reference | 9M 2019 | FY 2018 | 9M 2018 |
|---|---|---|---|---|
| Belgium Business Unit (A) | Company presentation on www.kbc.com | 197,0 | 186,4 | 200,3 |
| + | ||||
| Czech Republic Business Unit (B) | 10,4 | 9,5 | 9,7 | |
| + | ||||
| International Markets Business Unit (C) | 4,8 | 4,4 | 4,3 | |
| A)+(B)+(C) | 212,2 | 200,3 | 214,3 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.